Carrizo Oil & Gas, Inc. UNDERWRITING AGREEMENT
Exhibit 1.1
$325,000,000
Carrizo Oil & Gas, Inc.
4.375% Convertible Senior Notes due 2028
May 21, 2008
CREDIT SUISSE SECURITIES (USA) LLC
As Representative of the Several Underwriters,
c/o | Credit Suisse Securities (USA) LLC, Eleven Madison Avenue, New York, N.Y. 10010-3629 |
Ladies and Gentlemen:
Carrizo Oil & Gas, Inc., a Texas corporation (the “Issuer”), agrees with the several
underwriters named in Schedule I hereto (the “Underwriters”), for whom Credit Suisse Securities
(USA) LLC (“Credit Suisse”) is acting as representative (the “Representative”) to issue and sell to
the several Underwriters an aggregate principal amount of $325,000,000 of 4.375% Convertible Senior
Notes due 2028 (the “Firm Securities”) convertible into shares of the Issuer’s common stock, $.01
par value per share (the “Common Stock”). The shares of Common Stock into which the Securities are
convertible are referred to as the “Underlying Shares.” The respective amounts of the Firm
Securities to be so purchased by the several Underwriters are set forth opposite their names in
Schedule I hereto. The Issuer also proposes to sell to the Underwriters at the Underwriters’
option an aggregate of up to $48,750,000 principal amount of additional 4.375% Convertible Senior
Notes due 2028 (the “Option Securities”). The Firm Securities and Option Securities (collectively
the “Securities”) all to be issued under an indenture to be dated as of the Closing Date (as
defined below), as amended and supplemented (the “Original Indenture”), between Xxxxx Fargo Bank,
National Association, as trustee (the “Trustee”), the Issuer and the other parties named therein,
as to be supplemented with respect to the Securities by the First Supplemental Indenture to be
dated as of the Closing Date, among the Trustee and the Issuer (the “First Supplemental Indenture”
and, together with the Original Indenture, the “Indenture”).
As the Representative, Credit Suisse has advised the Issuer that (a) it is authorized to enter
into this Agreement on behalf of the several Underwriters, and (b) the several Underwriters are
willing, acting severally and not jointly, to purchase the principal amount of Firm Securities set
forth opposite their respective names in Schedule I, plus their pro rata portion of the principal
amount of Option Securities if the Representative elects to exercise the option described in
Section 3(c) in whole or in part for the accounts of the several Underwriters.
The Issuer has filed a registration statement on Form S-3 (File No. 333-142346) with respect
to the Securities and the Underlying Shares, including a base prospectus (as amended to the date of
this Agreement, the “Base Prospectus”) to be used in connection with the public offering and sale
of the Securities, pursuant to the Securities Act of 1933, as amended (the “Securities Act”), and
the rules and regulations (the “Rules and Regulations”) of the United States Securities and
Exchange Commission (the “Commission”) thereunder. As used in this Agreement, “Effective Time”
means the date and the time as of which such registration statement, or the most recent
post-effective amendment thereto, if any, became effective; “Effective Date” means the date of the
Effective Time; “Registration Statement” means such registration statement, as amended at the
Effective Time, including all information deemed to be a part of the registration statement
pursuant to Rule 430A, 430B or 430C under the Securities Act and the Rules and Regulations;
“Preliminary Prospectus” means the preliminary prospectus supplement, together with the Base
Prospectus, relating to the Securities included in such registration statement or filed with the
Commission pursuant to Rule 424(b) of the Rules and Regulations, dated May 20, 2008; “Prospectus
Supplement” means the prospectus supplement to be filed promptly after the date hereof pursuant to
Rule 424 and describing the Securities and the offering thereof; “Prospectus” means the Prospectus
Supplement, together with the Base Prospectus, in the form first used by the Underwriters to
confirm sales of the Securities or in the form first made available to the Underwriters by the
Issuer to meet requests of purchasers pursuant to Rule 173 under the Securities Act; “Free Writing
Prospectus” means any “free writing prospectus” as defined in Rule 405 under the Securities Act
relating to the Securities; “Issuer Free Writing Prospectus” means any “issuer free writing
prospectus” as defined in Rule 433 under the Securities Act relating to the Securities; and
“Disclosure Package” means the Base Prospectus, as amended or supplemented immediately prior to the
Applicable Time, including the most recent Preliminary Prospectus, together with the Issuer Free
Writing Prospectuses identified on Schedule II hereto, if any, and the information set forth on
Schedule III hereto. For purposes of clarity, any Free Writing Prospectus that was prepared by or
on behalf of, or used by, an offering participant other than the Issuer (without regard to whether
the conditions set forth in Rule 433 are satisfied with respect thereto) (each, an “Offering
Participant Free Writing Prospectus”) shall be excluded from the definitions of Registration
Statement, Base Prospectus, Prospectus Supplement, Preliminary Prospectus, Prospectus, Free Writing
Prospectus, Issuer Free Writing Prospectus and Disclosure Package. For the purposes of this
Agreement, the “Applicable Time” is 6:00 p.m. (Eastern time) on the date of this Agreement. Any
reference herein to the Registration Statement, any Preliminary Prospectus, the Base Prospectus,
the Prospectus Supplement or the Prospectus shall be deemed to refer to and include the documents
incorporated by reference therein pursuant to Item 12 of Form S-3 which were filed under the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), on or before the Effective Date
of the Registration Statement, the date of such Preliminary Prospectus, the date of such Base
Prospectus, the date of such Prospectus Supplement or the date of the Prospectus, as the case may
be, and any reference herein to the terms “amend,” “amendment” or “supplement” with respect to the
Registration Statement, the Base Prospectus, the Prospectus Supplement or the Prospectus shall be
deemed to refer to and include (i) the filing of any document under the Exchange Act after the
Effective Date of the Registration Statement, the date of such Preliminary Prospectus, the date of
such Base Prospectus, the date of such Prospectus Supplement or the date of the Prospectus, as the
case may be, which is incorporated therein by reference and (ii) any such document so filed. For
purposes of this Agreement, all references to the Registration
2
Statement, any Preliminary Prospectus, the Base Prospectus, the Prospectus Supplement, the
Prospectus or Issuer Free Writing Prospectus or to any amendment or supplement thereto shall be
deemed to include any copy filed with the Electronic Data Gathering Analysis and Retrieval System,
or XXXXX.
The Issuer and the Underwriters, in accordance with the requirements of Rule 2710(h) (“Rule
2710(h)”) of the Conduct Rules of the National Association of Securities Dealers, Inc. (which are
part of the rules of the Financial Industry Regulatory Authority, Inc. (“FINRA”)) (the “Conduct
Rules”) and subject to the terms and conditions stated herein, also hereby confirm the engagement
of the services of RBC Capital Markets Corporation as a “qualified independent underwriter” within
the meaning of Rule 2720(b)(15) in connection with the offering and sale of the Securities. RBC
Capital Markets Corporation in its capacity as qualified independent underwriter and not otherwise,
is referred to herein as the “QIU.”
In consideration of the mutual agreements contained herein and of the interests of the parties
in the transactions contemplated hereby, the parties hereto agree as follows:
1. Representations and Warranties of the Issuer.
The Issuer represents and warrants to each of the Underwriters as follows:
(a) As of the applicable determination date relating to (A) the initial filing of the
Registration Statement, (B) the most recent amendment thereto for the purposes of complying with
Section 10(a)(3) of the Securities Act (whether such amendment was by post-effective amendment,
incorporated report filed pursuant to Section 13 or 15(d) of the Exchange Act or form of
prospectus), and (C) the time the Issuer or any person acting on its behalf (within the meaning,
for this clause only, of Rule 163(c)) made any offer relating to the Securities in reliance on the
exemption of Rule 163, the Issuer was a “well-known seasoned issuer” as defined in Rule 405,
including not having been an “ineligible issuer” as defined in Rule 405. The Registration
Statement has been filed with the Commission under the Securities Act and has become effective
under the Securities Act. The Registration Statement is an “automatic shelf registration
statement” as defined under Rule 405 of the Securities Act that has been filed with the Commission
not earlier than three years prior to the date hereof; and no notice of objection of the Commission
to the use of such registration statement or any post-effective amendment thereto pursuant to Rule
401(g)(2) under the Securities Act has been received by the Issuer. No stop order suspending the
effectiveness of the Registration Statement is in effect, and no proceedings for such purpose are
pending before or, to the knowledge of the Issuer, threatened by the Commission. The Commission has
not issued any order preventing or suspending the use of the Prospectus or any Issuer Free Writing
Prospectus. Copies of the Registration Statement and each of the amendments thereto have been
delivered by the Issuer to the Representative (provided that availability of the Registration
Statement and each amendment on XXXXX shall constitute delivery so long as the XXXXX copy is
substantially identical except as permitted by Regulation S-T). The Registration Statement
conforms, and any further amendments or supplements to the Registration Statement will conform at
the time they become effective or are filed with the Commission, in all material respects to the
requirements of the Securities Act and the Rules and Regulations. The Prospectus, as of its date,
will conform and, as it may be further supplemented by filings with the Commission, will conform,
on the Closing Date (as defined below) and each Option Closing Date (as defined below), in all
material respects to
3
the requirements of the Securities Act and the Rules and Regulations. As of the Effective
Date, the date hereof, the Closing Date (as defined below) and each Option Closing Date (as defined
below), if any, the Registration Statement, and any post-effective amendments, do not and will not,
contain an untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements therein not misleading; the Prospectus,
as of its date, will not, and, on the Closing Date and each Option Closing Date, as amended or
supplemented by filings with the Commission, will not, contain an untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading; and the Disclosure Package,
as of the Applicable Time, did not contain an untrue statement of a material fact or omit to state
a material fact necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading. Notwithstanding the foregoing, none of the representations
and warranties set forth in this Section 1(a) shall apply to statements or omissions in the
Registration Statement, or the Prospectus, or any amendment or supplement in reliance upon and in
conformity with written information furnished to the Issuer by any Underwriter through the
Representative expressly for use therein, such information being listed in Section 15 below.
(b) Other than the Registration Statement, the Prospectus and the Disclosure Package, the
Issuer (including its agents and representatives, other than the Underwriters in their capacity as
such) has not made, used, prepared, authorized, approved or referred to and will not prepare, make,
use, authorize, approve or refer to any Issuer Free Writing Prospectus other than (i) any document
not constituting a prospectus pursuant to Section 2(a)(10)(a) of the Securities Act or Rule 134
under the Securities Act or (ii) the documents listed on Schedule II hereto, any Issuer Free
Writing Prospectus that constitutes a “road show” (within the meaning specified in Rule 433 of the
Rules and Regulations) or any other written communications approved in writing in advance by the
Representative and, with respect to each such Free Writing Prospectus, the Issuer represents that
it has treated and agrees that it will treat each such Free Writing Prospectus as an “issuer free
writing prospectus,” as defined in Rule 433, and has complied and will comply with the requirements
of Rules 164 and 433 applicable to any Free Writing Prospectus, including timely filing with the
Commission where required, legending and record keeping. Each such Issuer Free Writing Prospectus
complied in all material respects with the Securities Act, has been or will be (within the time
period specified in Rule 433) filed in accordance with the Securities Act (to the extent required
thereby) and, when taken together with the most recent Preliminary Prospectus, the other Issuer
Free Writing Prospectuses identified on Schedule II and the information set forth on Schedule III,
such Issuer Free Writing Prospectus, did not, and, when taken together with the Prospectus, the
other Issuer Free Writing Prospectuses identified on Schedule II and the information set forth on
Schedule III, at the Closing Date and as of the Option Closing Date, as the case may be, will not,
contain any untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not
misleading; provided that the Issuer makes no representation and warranty with respect to
any statements or omissions made in each such Issuer Free Writing Prospectus in reliance upon and
in conformity with information relating to any Underwriter furnished to the Issuer in writing by
such Underwriter through the Representative expressly for use in such Issuer Free Writing
Prospectus, it being understood and agreed that the only such information furnished by any
Underwriter consists of the information described as such in Section 15 hereof; provided,
further, that the Issuer makes no representation and warranty with respect to any
statements or omissions made in any Offering Participant Free Writing Prospectus, including any
issuer information (as defined in Rule 433 under
4
the Securities Act) therein. Each such Issuer Free Writing Prospectus, as of its issue date
and at all subsequent times through the completion of the public offering and sale of the
Securities did not, does not and will not include any information that conflicted, conflicts or
will conflict with the information contained in the Registration Statement or the Prospectus,
including any document incorporated by reference therein and any Preliminary Prospectus deemed to
be a part thereof that has not been superseded or modified.
(c) The documents incorporated by reference in the Registration Statement, the most recent
Preliminary Prospectus, the Prospectus and the Disclosure Package, at the time they became
effective or were filed with the Commission, as the case may be, complied in all material respects
with the requirements of the Securities Act or the Exchange Act, as applicable, and none of such
documents, when read together with the other information in the Disclosure Package, contained an
untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading, and any further documents so filed and incorporated by
reference in the Registration Statement, the Prospectus and the Disclosure Package, when such
documents become effective or are filed with the Commission, as the case may be, will conform in
all material respects to the requirements of the Securities Act or the Exchange Act, as applicable,
and will not, when read together with the other information in the Disclosure Package, contain an
untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances under which they are
made, not misleading.
(d) The financial statements of the Issuer (including all notes and schedules thereto)
included or incorporated by reference in the Registration Statement, the Prospectus and the
Disclosure Package present fairly in all material respects the financial position of the Issuer and
its consolidated subsidiaries at the dates indicated and the statement of operations, shareholders’
equity and cash flows of the Issuer and its consolidated subsidiaries for the periods specified;
and such financial statements and related schedules and notes thereto, have been prepared in
conformity with U.S. generally accepted accounting principles, consistently applied throughout the
periods involved. The summary and selected financial data included in the Prospectus and the
Disclosure Package present fairly in all material respects the information shown therein as at the
respective dates and for the respective periods specified and have been presented on a basis
consistent with the consolidated financial statements set forth in the Prospectus and the
Disclosure Package and other financial information.
(e) Xxxxxxx Xxxx Xxxxxxx of Texas, P.C., which has certified certain financial statements of
the Issuer and delivered its opinion with respect to the audited financial statements and schedules
included or incorporated by reference in the Registration Statement and the Prospectus, is an
independent registered public accounting firm with respect to the Issuer within the meaning of the
Securities Act, the Exchange Act and the rules and regulations of the Commission thereunder.
(f) The Issuer and each of the subsidiaries of the Issuer listed in Exhibit A hereto, which
list includes all “significant subsidiaries” as defined in Rule 405 of the Rules and Regulations,
(collectively, the “Subsidiaries”), is duly organized, validly existing and in good standing under
the laws of their respective jurisdictions of incorporation or organization. The Issuer
5
and each of its Subsidiaries is duly qualified to do business and is in good standing as a
foreign corporation in each jurisdiction in which the nature of the business conducted by it or
location of the assets or properties owned, leased or licensed by it requires such qualification,
except for such jurisdictions where the failure to so qualify individually or in the aggregate
would not have a material adverse effect on the assets, properties, condition, financial or
otherwise, or in the results of operations, business affairs or business prospects of the Issuer
and its Subsidiaries considered as a whole (a “Material Adverse Effect”); and to the Issuer’s
knowledge, no proceeding has been instituted in any such jurisdiction revoking, limiting or
curtailing, or seeking to revoke, limit or curtail, such power and authority or qualification.
Other than the Subsidiaries and as disclosed in the Registration Statement, the Issuer does not
own, directly or indirectly, any shares of capital stock and does not have any other equity or
ownership or proprietary interest in any corporation, partnership, association, trust, limited
liability company, joint venture or other entity.
(g) The Issuer and each of its Subsidiaries has all requisite corporate power and authority,
and all necessary authorizations, approvals, consents, orders, licenses, certificates and permits
of and from all governmental or regulatory bodies or any other person or entity (collectively, the
“Permits”), to own, lease and license its assets and properties and conduct its business, all of
which are valid and in full force and effect, except where the lack of such Permits, individually
or in the aggregate, would not have a Material Adverse Effect. The Issuer and each of its
Subsidiaries has fulfilled and performed in all material respects all of its material obligations
with respect to such Permits and no event has occurred that allows, or after notice or lapse of
time would allow, revocation or termination thereof or results in any other material impairment of
the rights of the Issuer thereunder. Neither the Issuer nor any of its Subsidiaries has received
notice of any reservation or modification of any such Permits or has any reason to believe that any
such Permits will not be reserved in the ordinary course, except as would not have a Material
Adverse Effect.
(h) Except as disclosed in the Registration Statement, the Prospectus and the Disclosure
Package, the Issuer and each of its Subsidiaries has (i) defensible title to all their interests in
the oil and gas properties described in the Registration Statement, the Prospectus and the
Disclosure Package as being owned or leased by them, title investigations having been carried out
by the Issuer in accordance with customary practice in the oil and gas industry, and (ii) good and
marketable title to all other real property and all personal property described in the Registration
Statement, the Prospectus and the Disclosure Package as being owned by them, in each case free and
clear of all liens, encumbrances, claims, security interests and defects, except (A) such as would
not have a Material Adverse Effect, (B) security interests securing loans under the Issuer’s senior
secured revolving credit facility and second lien credit facility, (C) royalties, overriding
royalties and other similar burdens under oil and gas leases, (D) easements, restrictions and
rights-of-way that commonly affect oil and gas properties and (E) liens and encumbrances under gas
sales contracts, geophysical exploration agreements, operating agreements, farmout agreements,
participation agreements, unitization, pooling and commutation agreements, declarations and orders
and gas sales contracts, securing payment of amounts not yet due and payable and of a scope and
nature customary in the oil and gas industry. All property held under lease by the Issuer and its
Subsidiaries is held by them under valid, existing and enforceable leases, free and clear of all
liens, encumbrances, claims, security interests and defects, except such as would not have a
Material Adverse Effect.
6
(i) There are no legal, governmental or regulatory actions, suits, proceedings or
investigations to which the Issuer or any of its Subsidiaries are subject or which is pending or,
to the knowledge of the Issuer, threatened, against the Issuer or any of its Subsidiaries, which,
individually or in the aggregate, might have a Material Adverse Effect, affect the consummation of
this Agreement or which are required to be disclosed in the Registration Statement, the Prospectus
and the Disclosure Package that are not so disclosed.
(j) Subsequent to the respective dates as of which information is given in the Registration
Statement, the Prospectus or the Disclosure Package, except as described therein, (i) there has not
been any Material Adverse Effect; (ii) neither the Issuer nor any of its Subsidiaries has sustained
any loss or interference with its assets, businesses or properties (whether owned or leased) from
fire, explosion, earthquake, flood or other calamity, whether or not covered by insurance, or from
any labor dispute or any court or legislative or other governmental action, order or decree which
would have a Material Adverse Effect; and (iii) since the date of the latest balance sheet included
or incorporated by reference in the Registration Statement, the Prospectus and the Disclosure
Package, neither the Issuer nor its Subsidiaries has (A) issued any securities, other than shares
issued pursuant to employee benefit plans, qualified stock options plans or other employee
compensation plans or pursuant to outstanding options, rights or warrants or incurred any liability
or obligation, direct or contingent, for borrowed money, except such liabilities or obligations
incurred in the ordinary course of business, (B) entered into any transaction or incurred any
liability or obligation, direct or contingent that were not in the ordinary course of business or
(C) declared or paid any dividend or made any distribution on any shares of its capital stock or
redeemed, purchased or otherwise acquired or agreed to redeem, purchase or otherwise acquire any
shares of its capital stock, other than with respect to the acquisition of shares of its Common
Stock in connection with payment of taxes required in connection with the exercise of options for
the purchase of Common Stock or the vesting of restricted stock.
(k) There is no document, contract or other agreement required to be described in the
Registration Statement, Prospectus or the Disclosure Package or to be filed as an exhibit to the
Registration Statement which is not described or filed as required by the Securities Act or the
Rules and Regulations. Each description of a contract, document or other agreement in the
Registration Statement, the Prospectus and the Disclosure Package accurately reflects in all
material respects the terms of the underlying contract, document or other agreement. Each contract,
document or other agreement described in the Registration Statement, the Prospectus or the
Disclosure Package or listed in the Exhibits to the Registration Statement is in full force and
effect and is valid and enforceable by and against the Issuer or its Subsidiary, as the case may
be, in accordance with its terms except as the enforceability thereof may be limited by bankruptcy,
insolvency, reorganization, fraudulent conveyance, moratorium or other similar laws relating to or
affecting the enforcement of creditors’ rights generally and by general principles of equity or
public policy (regardless of whether enforcement is sought in a proceeding at law or in equity).
Neither the Issuer nor any of its Subsidiaries, if a Subsidiary is a party, nor to the Issuer’s
knowledge, any other party is in default in the observance or performance of any term or obligation
to be performed by it under any such agreement, and no event has occurred which with notice or
lapse of time or both would constitute such a default, in any such case which default or event,
individually or in the aggregate, would have a Material Adverse Effect. No default exists, and no
event has occurred which with notice or lapse of time or both would constitute a default, in the
due performance and observance of any term, covenant or condition, by the Issuer or its Subsidiary,
if a Subsidiary is a
7
party thereto, of any other agreement or instrument to which the Issuer or any of its
Subsidiaries is a party or by which Issuer or its properties or business or a Subsidiary or its
properties or business may be bound or affected which default or event, individually or in the
aggregate, would have a Material Adverse Effect.
(l) Neither the Issuer nor any of its Subsidiaries is (i) in violation of any term or
provision of its charter or Bylaws or similar organizational documents or (ii) in violation of any
franchise, license, permit, judgment, decree, order, statute, rule or regulation, where the
consequences of such violation in this subsection (ii), individually or in the aggregate, would
have a Material Adverse Effect.
(m) Neither the execution, delivery and performance of this Agreement by the Issuer nor the
consummation of any of the transactions contemplated hereby (including, without limitation, the
issuance and sale by the Issuer of the Securities) will give rise to a right to terminate or
accelerate the due date of any payment due under, or conflict with or result in the breach of any
term or provision of, or constitute a default (or an event which with notice or lapse of time or
both would constitute a default) under, or require any consent or waiver under, or result in the
execution or imposition of any lien, charge or encumbrance upon any properties or assets of the
Issuer or its Subsidiaries pursuant to the terms of, any indenture, mortgage, deed of trust or
other agreement or instrument to which the Issuer or any of its Subsidiaries is a party or by which
either the Issuer or its Subsidiaries or any of their properties or businesses is bound, or any
franchise, license, permit, judgment, decree, order, statute, rule or regulation applicable to the
Issuer or any of its Subsidiaries or violate any provision of the charter or Bylaws of the Issuer
or any of its Subsidiaries, except for such consents or waivers which have already been obtained
and are in full force and effect and except as would not have a Material Adverse Effect.
(n) The Indenture has been duly authorized by the Issuer and has been duly qualified under,
and conforms in all material respects to the requirements of, the Trust Indenture Act of 1939, as
amended and the rules and regulations promulgated thereunder (collectively, the “Trust Indenture
Act”); the Securities have been duly authorized by the Issuer and when the Securities are duly
executed, authenticated, issued, delivered and paid for pursuant to this Agreement on each Closing
Date, such Securities will have been duly and validly issued and outstanding, will conform in all
material respects to the information in the Disclosure Package and to the description of such
Securities contained in the Final Prospectus and such Securities will constitute legal, valid and
binding obligations of the Issuer, enforceable against the Issuer in accordance with their terms,
subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws
of general applicability relating to or affecting creditors’ rights and to general equity
principles (regardless of whether such enforceability is considered in a proceeding in equity or at
law). When the Indenture is executed and delivered by the Issuer and the subsidiaries of the
Issuer parties thereto, assuming the due authorization, execution and delivery of the Indenture by
the Trustee, the Indenture will be a legal, valid and binding agreement of the Issuer, enforceable
against the Issuer in accordance with its terms, subject to bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium and similar laws of general applicability relating to or
affecting creditors’ rights and to general equity principles (regardless of whether such
enforceability is considered in a proceeding in equity or at law). The statements in the
Disclosure Package and the Final Prospectus under the headings “Description of the Notes” and
“Material U.S. Federal Income and Estate Tax Considerations” insofar as such statements summarize
legal matters, agreements, document or
8
proceedings discussed therein, are accurate and fair summaries of such legal matters,
agreements, documents or proceedings and present the information required to be shown.
(o) The Issuer has authorized and has outstanding capital stock as set forth under the
captions “Capitalization” and “Description of Capital Stock” in the Prospectus and the Disclosure
Package. The certificates evidencing the Common Stock are in due and proper legal form. All of the
issued and outstanding shares of Common Stock have been duly and validly issued and are fully paid
and nonassessable.
(p) When the Securities are issued and authenticated in accordance with the terms of the
Indenture and delivered and paid for pursuant to this Agreement on each Closing Date, such
Securities will be convertible into the Underlying Shares of the Issuer in accordance with the
terms of the Indenture. There are no statutory preemptive or other similar rights to subscribe for
or to purchase or acquire any of the Securities or Underlying Shares or any such rights pursuant to
its articles of incorporation or Bylaws or any agreement or instrument to or by which the Issuer or
any of its Subsidiaries is a party or bound. The Underlying Shares have been duly authorized by the
Issuer and when issued on conversion in accordance with the terms of the Indenture will be duly and
validly issued, fully paid and nonassessable and none of them will be issued in violation of any
preemptive or other similar right. Except as disclosed in the Registration Statement, the
Prospectus and the Disclosure Package, there is no outstanding option, warrant or other right
calling for the issuance of, and there is no commitment, plan or arrangement to issue, any share of
capital stock of the Issuer or any of its Subsidiaries or any security convertible into, or
exercisable or exchangeable for, such capital stock. The Common Stock and the Underlying Shares
conform in all material respects to all statements in relation thereto contained in the
Registration Statement, the Prospectus and the Disclosure Package. All outstanding shares of
capital stock of each of the Issuer’s Subsidiaries have been duly authorized by all necessary
corporate action and validly issued, and are fully paid and nonassessable and are owned directly by
the Issuer or by another wholly-owned Subsidiary of the Issuer free and clear of any security
interests, liens, encumbrances, equities or claims, other than those described in the Registration
Statement, the Prospectus and the Disclosure Package.
(q) No holder of any security of the Issuer has any right, which has not been waived or
satisfied, to have any security owned by such holder included in the Registration Statement or to
demand registration of any security owned by such holder. Each director and executive officer of
the Issuer has delivered to the Representative his enforceable written lock-up agreement in the
form attached to this Agreement as Exhibit B hereto or such other form as is approved by the
Representative (each, a “Lock-Up Agreement”).
(r) All necessary corporate action has been duly and validly taken by the Issuer to authorize
the execution, delivery and performance of this Agreement and the issuance and sale of the
Securities by the Issuer and the issuance by the Issuer of Underlying Shares upon conversion of the
Securities. This Agreement has been duly and validly authorized by all necessary corporate action,
executed and delivered by the Issuer and constitutes and will constitute legal, valid and binding
obligations of the Issuer enforceable against the Issuer in accordance with its terms, except as
the enforceability thereof may be limited by bankruptcy, insolvency, reorganization, fraudulent
conveyance, moratorium or other similar laws relating to or affecting the enforcement of creditors’
9
rights generally and by general principles of equity or public policy (regardless of whether
enforcement is sought in a proceeding at law or in equity).
(s) Neither the Issuer nor any of its Subsidiaries is involved in any labor dispute nor, to
the knowledge of the Issuer, is any such dispute threatened, which dispute would have a Material
Adverse Effect. The Issuer is not aware of any existing or imminent labor disturbance by the
employees of any of its principal suppliers or contractors which would have a Material Adverse
Effect. The Issuer is not aware of any threatened or pending litigation between the Issuer or its
Subsidiaries and any of its executive officers which, if adversely determined, could have a
Material Adverse Effect and has no reason to believe that such officers will not remain in the
employment of the Issuer.
(t) No transaction has occurred between or among the Issuer and any of its officers or
directors, shareholders or any affiliate or affiliates of any such officer or director or
shareholder that is required to be described in and is not described in the Registration Statement,
the Prospectus and the Disclosure Package.
(u) The Issuer has not taken, nor will it take, directly or indirectly, any action designed to
or which might reasonably be expected to cause or result in, or which has constituted or which
might reasonably be expected to constitute, the stabilization or manipulation of the price of the
Common Stock or any security of the Issuer.
(v) The Issuer and each of its Subsidiaries has filed all federal, state, local and foreign
tax returns which are required to be filed through the date hereof, except where the failure to so
file would not have a Material Adverse Effect, which returns are true and correct in all material
respects or has received timely extensions thereof, and has paid all taxes shown on such returns
and all assessments received by it to the extent that the same are material and have become due,
except for such taxes as are being contested in good faith and except as would not result in a
Material Adverse Effect. There are no tax audits or investigations pending, which if adversely
determined would have a Material Adverse Effect; nor are there any material proposed additional tax
assessments against the Issuer or any of its Subsidiaries.
(w) The Issuer has taken no action designed to, or likely to have the effect of, terminating
the registration of the Common Stock under the Exchange Act or the listing of the Common Stock on
The Nasdaq Stock Market, nor has the Issuer received any notification that the Commission or The
Nasdaq Stock Market is contemplating terminating such registration or listing.
(x) The books, records and accounts of the Issuer and its Subsidiaries accurately and fairly
reflect, in reasonable detail, the transactions in, and dispositions of, the assets of, and the
results of operations of, the Issuer and its Subsidiaries. The Issuer and each of its Subsidiaries
maintains a system of internal accounting controls sufficient to provide reasonable assurances that
(i) transactions are executed in accordance with management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with management’s general or specific
authorization and (iv) the recorded accountability for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any differences.
10
(y) The written engineering reports prepared by (i) Xxxxx Xxxxx Company, L.P., (ii) Xxxxxxxxx
& Xxxxx, Inc. and (iii) XxXxxxx Petroleum Consultants, Ltd. (together, the “Independent Petroleum
Engineers”), as of December 31, 2006 and 2007, respectively, setting forth the engineering values
attributed to the oil and gas properties of the Issuer and its Subsidiaries accurately reflect in
all material respects the ownership interests of the Issuer and its subsidiaries in the properties
therein as of December 31, 2006 and 2007, respectively, except as otherwise disclosed in the
Registration Statement, the Prospectus and the Disclosure Package. The information furnished by the
Issuer to the Independent Petroleum Engineers for purposes of preparing their reports, including,
without limitation, production, costs of operation and development, current prices for production,
agreements relating to current and future operations and sales of production, was true, correct and
complete in all material respects on the date supplied and was prepared in accordance with
customary industry practices; each of the Independent Petroleum Engineers, who prepared estimates
of the extent and value of proved oil and natural gas reserves, are independent with respect to the
Issuer.
(z) The Issuer and its Subsidiaries are insured by insurers of recognized financial
responsibility against such losses and risks and in such amounts as are customary in the businesses
in which they are engaged or propose to engage after giving effect to the transactions described in
the Prospectus and the Disclosure Package; all policies of insurance and fidelity or surety bonds
insuring the Issuer or any of its Subsidiaries or the Issuer’s or its Subsidiaries’ respective
businesses, assets, employees, officers and directors are in full force and effect; the Issuer and
each of its Subsidiaries are in compliance with the terms of such policies and instruments in all
material respects; and neither the Issuer nor any Subsidiary of the Issuer has any reason to
believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary to continue its
business at a cost that is not materially greater than the current cost, except as would not have a
Material Adverse Effect.
(aa) Each approval, consent, order, authorization, designation, declaration or filing of, by
or with any regulatory, administrative or other governmental body necessary in connection with the
execution and delivery by the Issuer of this Agreement and the consummation of the transactions
herein contemplated required to be obtained or performed by the Issuer (except such additional
steps as may be necessary to qualify the Securities or the Underlying Shares for public offering by
the Underwriters under the state securities or blue sky laws and except for the filing of any
issuer information contained in any Offering Participant Free Writing Prospectus) has been obtained
or made and is in full force and effect, except as would not have a Material Adverse Effect.
(bb) There are no affiliations with the FINRA among the Issuer’s officers, directors or, to
the knowledge of the Issuer, any five percent or greater shareholder of the Issuer, except as set
forth in the Prospectus or the Disclosure Package or otherwise disclosed in writing to the
Representative.
(cc) Except as described in the Registration Statement, the Prospectus and the Disclosure
Package, (i) each of the Issuer and each of its Subsidiaries is in compliance in all material
respects with all rules, laws and regulations relating to the use, treatment, storage and disposal
of toxic substances and protection of health or the environment (“Environmental Law”)
11
which are applicable to its business; (ii) neither the Issuer nor its Subsidiaries has
received any notice from any governmental authority or third party of an asserted claim under
Environmental Laws, which claim if determined adverse to the Issuer or any Subsidiary could have a
Material Adverse Effect; (iii) each of the Issuer and each of its Subsidiaries has received all
material permits, licenses or other approvals required of it under applicable Environmental Laws to
conduct its business and is in compliance with all terms and conditions of any such permit, license
or approval, except where the absence of such permit, license, approval or compliance would not
result in a Material Adverse Effect; (iv) to the Issuer’s knowledge, no facts currently exist that
will require the Issuer or any of its Subsidiaries to make future material capital expenditures to
comply with Environmental Laws; (v) no property which is or has been owned, leased or occupied by
the Issuer or its Subsidiaries has been designated as a Superfund site pursuant to the
Comprehensive Environmental Response, Compensation of Liability Act of 1980, as amended (42 U.S.C.
Section 9601, et. seq.) (“CERCLA”) or otherwise designated as a contaminated site under applicable
state or local law; (vi) neither the Issuer nor any of its Subsidiaries has been named as a
“potentially responsible party” under CERCLA; (vii) there has been no storage, disposal,
generation, transportation, handling or treatment of hazardous substances or solid wastes by the
Issuer (or to the knowledge of the Issuer, any of its predecessors in interest) at, upon or from
any of the property now or previously owned or leased by the Issuer in violation of any applicable
law, ordinance, rule, regulation, order, judgment, decree or permit or which would require remedial
action by the Issuer under any applicable law, ordinance, rule, regulation, order, judgment, decree
or permit, except for any violation or remedial action which would not result in, or which would
not be reasonably likely to result in, singularly or in the aggregate with all such violations and
remedial actions, a Material Adverse Effect; and (viii) there has been no spill, discharge, leak,
emission, injection, escape, dumping or release of any kind onto such property or into the
environment surrounding such property of any solid wastes or hazardous substances due to or caused
by the Issuer, except for any spill, discharge, leak, emission, injection, escape, dumping or
release which would not result in or would not be reasonably likely to result in, singularly or in
the aggregate will all such spills, discharges, leaks, emissions, injections, escapes, dumpings and
releases, a Material Adverse Effect; and the terms “hazardous substances” and “solid wastes” shall
have the meanings specified in any applicable local, state and federal laws or regulations with
respect to environmental protection.
(dd) In the ordinary course of its business, the Issuer periodically reviews the effect of
Environmental Laws on the business, operations and properties of the Issuer and its Subsidiaries,
in the course of which the Issuer identifies and evaluates associated costs and liabilities
(including, without limitation, any capital or operating expenditures required for clean-up,
closure of properties or compliance with Environmental Laws, or any permit, license or approval,
any related constraints on operating activities and any potential liabilities to third parties). On
the basis of such review, the Issuer has reasonably concluded that such associated costs and
liabilities would not, singly or in the aggregate, have a Material Adverse Effect.
(ee) The Issuer is not and, after giving effect to the offering and sale of the Securities and
the application of proceeds thereof as described in the Prospectus and the Disclosure Package, will
not be an “investment company” within the meaning of the Investment Company Act of 1940, as
amended, and the rules and regulations of the Commission thereunder (collectively, the “1940 Act”).
12
(ff) The principal executive officer and principal financial officer of the Issuer have made
all certifications required by the Xxxxxxxx-Xxxxx Act of 2002 (the “Xxxxxxxx-Xxxxx Act”) or any
related rules and regulations promulgated by the Commission, and the statements contained in any
such certification are true and correct in all material respects. The Issuer maintains “disclosure
controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act), and
such controls and procedures are designed (i) to ensure that information required to be disclosed
by the Issuer in the reports that it files or submits under the Exchange Act is recorded,
processed, summarized and reported, within the time periods specified in the Commission’s rules and
forms and (ii) to ensure that information required to be disclosed by the Issuer in the reports
that it files or submits under the Exchange Act is accumulated and communicated to the Issuer’s
management, including its principal executive officer and principal financial officer, as
appropriate to allow timely decisions regarding required disclosure. Except as set forth in the
Preliminary Prospectus and the Prospectus, the Issuer does not have any material weaknesses in
internal controls, and there has been no material fraud that involves management or other employees
who have a significant role in the Issuer’s internal controls. The Issuer is otherwise in
compliance in all material respects with all applicable effective provisions of the Xxxxxxxx-Xxxxx
Act and the rules and regulations promulgated by the Commission (and intends to comply with all
applicable provisions that are not yet effective upon effectiveness). The Issuer’s auditors and
the Audit Committee of the Board of Directors of the Issuer have been advised of: (i) all
significant deficiencies and material weaknesses in the design or operation of internal controls
over financial reporting which are reasonably likely to adversely affect the Issuer’s ability to
record, process, summarize and report financial information; and (ii) any fraud, whether or not
material, that involves management or other employees who have a significant role in the Issuer’s
internal controls over financial reporting.
(gg) The Issuer and its Subsidiaries maintain systems of “internal control over financial
reporting” (as defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements of
the Exchange Act and have been designed by, or under the supervision of, their respective principal
executive and principal financial officers, or persons performing similar functions, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting
principles, including, but not limited to internal accounting controls sufficient to provide
reasonable assurance that (i) transactions are executed in accordance with management’s general or
specific authorizations; (ii) transactions are recorded as necessary to permit preparation of
financial statements in conformity with generally accepted accounting principles and to maintain
asset accountability; (iii) access to assets is permitted only in accordance with management’s
general or specific authorization; and (iv) the recorded accountability for assets is compared with
the existing assets at reasonable intervals and appropriate action is taken with respect to any
differences.
(hh) The Issuer or any other person associated with or acting on behalf of the Issuer
including, without limitation, any director, officer, agent or employee of the Issuer or its
Subsidiaries, has not, directly or indirectly, while acting on behalf of the Issuer or its
Subsidiaries (i) used any corporate funds for unlawful contributions, gifts, entertainment or other
unlawful expenses relating to political activity; (ii) made any unlawful payment to foreign or
domestic government officials or employees or to foreign or domestic political parties or campaigns
from corporate funds; (iii) violated any provision of the Foreign Corrupt Practices Act of 1977, as
amended; or (iv) made any other unlawful payment.
13
(ii) The operations of the Issuer and its Subsidiaries are and have been conducted at all
times in compliance with applicable financial recordkeeping and reporting requirements of the
Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes
of all jurisdictions, the rules and regulations thereunder and any related or similar rules,
regulations or guidelines, issued, administered or enforced by any governmental agency
(collectively, the “Money Laundering Laws”) and no action, suit or proceeding by or before any
court or governmental agency, authority or body or any arbitrator involving the Issuer or any of
its subsidiaries with respect to the Money Laundering Laws is pending or, to the best knowledge of
the Issuer, threatened.
(jj) None of the Issuer, any of its Subsidiaries or, to the knowledge of the Issuer, any
director, officer, agent, employee or Affiliate of the Issuer or any of its subsidiaries is
currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the
U.S. Department of the Treasury (“OFAC”); and the Issuer will not directly or indirectly use the
proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make
available such proceeds to any subsidiary, joint venture partner or other person or entity, for the
purpose of financing the activities of any person currently subject to any U.S. sanctions
administered by OFAC.
(kk) Neither the Issuer nor any of its Subsidiaries is a party to any contract, agreement or
understanding with any person (other than this Agreement) that would give rise to a valid claim
against the Issuer or any of its Subsidiaries or any Underwriter for a brokerage commission,
finder’s fee or like payment in connection with the offering and sale of the Securities.
(ll) Except as described in the Prospectus and the Disclosure Package or in the documents
incorporated by reference into the Prospectus and the Disclosure Package, the Issuer has not sold
or issued any debt securities or shares of capital stock during the six-month period preceding the
date of the Prospectus, including any sales pursuant to Rule 144A under, or Regulations D or S of,
the Securities Act, other than shares of Common Stock issued pursuant to employee benefit plans,
qualified stock options plans or other employee compensation plans or pursuant to outstanding
options, rights or warrants.
(mm) The Issuer has fulfilled its obligations, if any, under the minimum funding standards of
Section 302 of the U.S. Employee Retirement Income Security Act of 1974 (“ERISA”) and the
regulations and published interpretations thereunder with respect to each “plan” as defined in
Section 3(3) of ERISA and such regulations and published interpretations in which its employees are
eligible to participate and each such plan is in compliance in all material respects with the
presently applicable provisions of ERISA and such regulations and published interpretations. No
“Reportable Event” (as defined in 12 ERISA) has occurred with respect to any “Pension Plan” (as
defined in ERISA) for which the Issuer could have any liability.
(nn) Each of the Issuer, its directors and officers has not distributed and will not
distribute prior to the later of (i) the Closing Date or the Option Closing Date, as applicable,
and (ii) completion of the distribution of the Securities, any offering material in connection with
the offering and sale of the Securities other than the Prospectus, the items included in the
Disclosure Package, the Registration Statement, any Issuer Free Writing Prospectus to which the
Representative has
14
consented, and other materials, if any, permitted by the Securities Act, including Rule 134 of
the Rules and Regulations.
2. Qualified Independent Underwriter Engagement.
(a) The Issuer hereby confirms its engagement without compensation of RBC Capital Markets
Corporation as, and RBC Capital Markets Corporation hereby confirms its agreement with the Issuer
to render services as, a “qualified independent underwriter” within the meaning of Rule 2720(b)(15)
of the Conduct Rules with respect to the offering and sale of the Securities.
(b) The QIU hereby consents to the references to it as set forth under the caption
“Underwriting” in the Disclosure Package and the Final Prospectus and in any amendment or
supplement thereto.
(c) The Issuer agrees to cooperate with the Underwriters and the QIU in an effort to enable
the Underwriters to comply with Rule
2710(h) and the QIU to perform the services contemplated by this Agreement.
2710(h) and the QIU to perform the services contemplated by this Agreement.
3. Purchase, Sale and Delivery of the Firm Securities.
(a) On the basis of the representations, warranties and covenants herein contained, and
subject to the conditions herein set forth, the Issuer agrees to sell to the Underwriters and each
Underwriter agrees, severally and not jointly, to purchase, at a price of 97.75% of the principal
amount thereof plus accrued interest from May 28, 2008 to the Closing Date, if any, the respective
principal amounts of Firm Securities set forth opposite the names of the Underwriters in Schedule I
hereto.
(b) The Issuer will deliver the Securities to or as instructed by the Representative for the
accounts of the several Underwriters in a form reasonably acceptable to the Representative against
payment of the purchase price by the Underwriters in federal (same day) funds by wire transfer to
an account at a bank acceptable to the Representative drawn to the order of the Issuer at the
office of Xxxxx Xxxxx L.L.P. 000 Xxxxxxxxx Xxxxxx, Xxxxxxx, Xxxxx 00000 , at 9:00 A.M., New York
time, on May 28, 2008, or at such other time not later than five full business days thereafter as
the Representative and the Issuer determine, such time being herein referred to as the “First
Closing Date”. For purposes of Rule 15c6-1 under the Securities Exchange Act of 1934, the First
Closing Date (if later than the otherwise applicable settlement date) shall be the settlement date
for payment of funds and delivery of securities for all the Securities sold pursuant to the
offering. The Securities so to be delivered or evidence of their issuance will be made available
for checking at the above office of Xxxxx Xxxxx L.L.P. at least 18 hours prior to the First Closing
Date.
(c) In addition, on the basis of the representations and warranties herein contained and
subject to the terms and conditions herein set forth, the Issuer hereby grants an option to the
several Underwriters to purchase the Option Securities at the price per share as set forth in the
first paragraph of this Section. The option granted hereby may be exercised in whole or in part by
giving written notice (i) at any time before the Closing Date and (ii) only once thereafter within
30 days after the date of this Agreement, by the Representative to the Issuer setting forth the
number of Option Securities as to which the several Underwriters are exercising the option, the
names and
15
denominations in which the Option Securities are to be registered and the time and date at
which such Securities are to be delivered. The time and date at which Securities for Option
Securities are to be delivered shall be determined by the Representative but shall not be earlier
than three nor later than 10 full business days after the exercise of such option, nor in any event
prior to the Closing Date (such time and date being herein referred to as the “Option Closing
Date”). If the date of exercise of the option is three or more days before the Closing Date, the
notice of exercise shall set the Closing Date as the Option Closing Date. The principal amount of
Option Securities to be purchased by each Underwriter shall be in the same proportion to the total
principal amount of Option Securities being purchased as the principal amount of Firm Securities
being purchased by such Underwriter bears to the total principal amount of Firm Securities,
adjusted by the Representative in such manner as to avoid fractions. The option with respect to
the Option Securities granted hereunder may be exercised only to cover
over-allotments in the sale of the Firm Securities by the Underwriters. The Representative may cancel such option at any time prior to its expiration by giving written notice of such cancellation to the Issuer. To the extent, if any, that the option is exercised, payment for and delivery of the Option Securities and delivery of the documents described in Section 7 hereof shall be made in the same manner as in the case of the Firm Securities.
over-allotments in the sale of the Firm Securities by the Underwriters. The Representative may cancel such option at any time prior to its expiration by giving written notice of such cancellation to the Issuer. To the extent, if any, that the option is exercised, payment for and delivery of the Option Securities and delivery of the documents described in Section 7 hereof shall be made in the same manner as in the case of the Firm Securities.
4. Offering by the Underwriters.
It is understood that the several Underwriters are to make a public offering of the Firm
Securities as soon as the Representative deems it advisable to do so. The Firm Securities are to
be offered to the public as set forth in the Disclosure Package and the Prospectus Supplement. To
the extent, if at all, that any Option Securities are purchased pursuant to Section 3 hereof, the
Underwriters will offer them to the public on the foregoing terms.
5. Covenants.
(a) The Issuer covenants and agrees with the several Underwriters that it will (i) prepare and
file the Prospectus Supplement with the Commission pursuant to Rule 424, (ii) not file any
amendment to the Registration Statement or supplement to the Prospectus or any Issuer Free Writing
Prospectus of which the Representative shall not previously have been advised and furnished with a
copy or to which the Representative shall have reasonably objected in writing or which is not in
compliance, in all material respects, with the Rules and Regulations; and (iii) file on a timely
basis all reports and any definitive proxy or information statements required to be filed by the
Issuer with the Commission subsequent to the date of the Prospectus and prior to the termination of
the offering of the Securities by the Underwriters.
(b) The Issuer has not distributed, and without the prior consent of the Representative it
will not distribute, any prospectus or other offering material (including, without limitation, any
offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or
otherwise constitute a Free Writing Prospectus required to be filed with the Commission and content
on the Issuer’s website that may be deemed to be a prospectus or other offering material) in
connection with the offering and sale of the Securities, other than the materials referred to in
Section 1(a). Each Underwriter represents and agrees that it has not made and, without the prior
consent of the Issuer and the Representative, it will not make, any offer relating to the
Securities that would constitute an Issuer Free Writing Prospectus or otherwise constitute a free
writing prospectus as defined in Rule 405 under the Securities Act and will not include any “issuer
16
information” (as defined in Rule 433) in any free writing prospectus, except as has been
disclosed in writing to the Issuer prior to the Applicable Time. Any such Issuer Free Writing
Prospectus the use of which has been consented to by the Issuer and the Representative is listed on
Schedule II hereto. The Issuer has complied and will comply with the requirements of Rule 433
under the Securities Act applicable to any Issuer Free Writing Prospectus, including timely filing
with the Commission or retention where required and legending, and each Underwriter has complied
and will comply with the requirements of Rule 433 under the Securities Act applicable to any
Offering Participant Free Writing Prospectus, including timely filing with the Commission or
retention where required and legending. The Issuer represents that it has satisfied and agrees
that it will satisfy the conditions under Rule 433 under the Securities Act to avoid a requirement
to file with the Commission any electronic road show. The Issuer agrees that if at any time
following issuance of an Issuer Free Writing Prospectus any event occurred or occurs as a result of
which such Issuer Free Writing Prospectus would conflict with the information in the Registration
Statement or the Prospectus or would include an untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading, the Issuer will give prompt notice
thereof to the Representative and, if requested by the Representative, will prepare and furnish
without charge to each Underwriter an Issuer Free Writing Prospectus or other document which will
correct such conflict, statement or omission; provided, however, that this representation and
warranty shall not apply to any statements or omissions in an Issuer Free Writing Prospectus made
in reliance upon and in conformity with information furnished in writing to the Issuer by an
Underwriter through the Representative expressly for use therein.
(c) The Issuer will prepare a final term sheet relating to the Securities, containing only
information that describes the final terms of the Securities and otherwise in a form consented to
by the Representative, and will file such final term sheet within the period required by
Rule 433(d)(5)(ii) under the Securities Act following the date such final terms have been established for the offering of the Securities. Any such final term sheet is an Issuer Free Writing Prospectus for purposes of this Agreement. The Issuer also consents to the use by any Underwriter of a Free Writing Prospectus that is not required to be filed with the Commission and that contains only (i)(x) information describing the preliminary terms of the Securities or their offering or (y) information that describes the final terms of the Securities or their offering and that is included in the final term sheet of the Issuer contemplated in the first sentence of this subsection or (ii) other information that is not “issuer information,” as defined in Rule 433, it being understood that any such Free Writing Prospectus referred to in clause (i) or (ii) above shall not be an Issuer Free Writing Prospectus for purposes of this Agreement.
Rule 433(d)(5)(ii) under the Securities Act following the date such final terms have been established for the offering of the Securities. Any such final term sheet is an Issuer Free Writing Prospectus for purposes of this Agreement. The Issuer also consents to the use by any Underwriter of a Free Writing Prospectus that is not required to be filed with the Commission and that contains only (i)(x) information describing the preliminary terms of the Securities or their offering or (y) information that describes the final terms of the Securities or their offering and that is included in the final term sheet of the Issuer contemplated in the first sentence of this subsection or (ii) other information that is not “issuer information,” as defined in Rule 433, it being understood that any such Free Writing Prospectus referred to in clause (i) or (ii) above shall not be an Issuer Free Writing Prospectus for purposes of this Agreement.
(d) The Issuer will advise the Representative promptly (i) when any post-effective amendment
to the Registration Statement shall have become effective; (ii) of receipt of any comments from the
Commission; (iii) of any request of the Commission for amendment of the Registration Statement or
for supplement to the Prospectus or for any additional information; and (iv) of the issuance by the
Commission of any stop order suspending the effectiveness of the Registration Statement or the use
of the Prospectus or of the institution of any proceedings for that purpose. The Issuer will use
its commercially reasonable efforts to prevent the issuance of any such stop order preventing or
suspending the use of the Prospectus and to obtain as soon as possible the lifting thereof, if
issued.
17
(e) The Issuer will cooperate with the Representative in endeavoring to qualify the Securities
for sale under the securities laws of such jurisdictions as the Representative may reasonably have
designated in writing and will make such applications, file such documents, and furnish such
information as may be reasonably required for that purpose, provided the Issuer shall not be
required to qualify as a foreign corporation or to file a general consent to service of process in
any jurisdiction where it is not now so qualified or required to file such a consent or subject
itself to taxation as doing business in any jurisdiction or qualify as a dealer of securities in
any jurisdiction. The Issuer will, from time to time, prepare and file such statements, reports,
and other documents, as are or may be required to continue such qualifications in effect for so
long a period as the Representative may reasonably request for distribution of the Securities.
(f) The Issuer will deliver to, or upon the order of, the Representative during the period
when delivery of a Prospectus is required under the Securities Act, as many copies of the
Prospectus in final form, or as thereafter amended or supplemented, as the Representative may
reasonably request. The Issuer will deliver to the Representative at or before the Closing Date,
signed copies of the Registration Statement and all amendments thereto including all exhibits filed
therewith, and will deliver to the Representative such number of copies of the Registration
Statement (including such number of copies of the exhibits filed therewith that may reasonably be
requested) and of all amendments thereto, as the Representative may reasonably request.
(g) The Issuer will comply with the Securities Act, the Rules and Regulations, the Exchange
Act and the Trust Indenture Act, and the rules and regulations of the Commission thereunder, so as
to permit the completion of the distribution of the Securities as contemplated in this Agreement
and the Prospectus. If during the period in which a prospectus is required by law to be delivered
by an Underwriter or dealer, any event shall occur as a result of which, in the judgment of the
Issuer or in the reasonable opinion of the Underwriters, the Prospectus, as then amended or
supplemented, would include any untrue statement of a material fact or omit to state any material
act necessary to make the statements therein, in the light of the circumstances under which they
were made, not misleading, or, if it is necessary at any time to amend or supplement the Prospectus
to comply with the Securities Act or the Rules and Regulations, the Issuer promptly will prepare
and file with the Commission an appropriate amendment to the Registration Statement or supplement
to the Prospectus.
(h) The Issuer will make generally available to its security holders and the Representative,
as soon as it is practicable to do so, but in any event not later than 15 months after the
effective date of the Registration Statement, an earning statement (which need not be audited) in
reasonable detail, covering a period of at least 12 consecutive months beginning after the
effective date of the Registration Statement, which earning statement shall satisfy the
requirements of Section 11(a) of the Securities Act and Rule 158 of the Rules and Regulations.
(i) The Issuer covenants and agrees that it will not offer, sell, contract to sell, pledge or
otherwise dispose of, directly or indirectly, or file with the SEC a registration statement or
amendment to a registration statement under the Securities Act relating to, any shares of its
common stock or securities convertible into or exchangeable or exercisable for any shares of its
common stock, or publicly disclose the intention to make any such offer, sale, pledge, disposition
or filing for a period of 60 days after the date of this Agreement, directly or indirectly,
otherwise than hereunder or with the prior written consent of the Representative; provided, that
this provision will not restrict
18
the Issuer from (i) issuances pursuant to the exercise of options outstanding on the date
hereof, (ii) grants of employee stock options and restricted stock and other securities issuances
pursuant to the terms of a plan in effect on the date hereof, (iii) issuances pursuant to the
exercise of such options, (iv) issuances to our employees under the terms of the employee stock
purchase plan in effect on the date hereof, (v) issuances pursuant to our 401(k) plan, (vi)
issuances to directors pursuant to the incentive plan in effect on the date hereof, (vii) the
filing of registration statements on Form S-8 and amendments thereto in connection with those
securities and plans, (viii) the filing of amendments to our currently effective resale shelf
registration statement, (ix) the taking any of the foregoing actions in connection with the
issuance of shares or other securities in connection with acquisitions and private placements by us
and (x) offerings and issuances in connection with an acquisition by the Issuer or any of its
subsidiaries of a business, entity or assets.
(j) The Issuer will use its best efforts to list, subject to notice of issuance, the
Underlying Shares on The Nasdaq Stock Market.
(k) The Issuer shall apply the net proceeds of its sale of the Securities as described under
the heading “Use of Proceeds” in the Prospectus and the Disclosure Package.
(l) The Issuer shall not invest, or otherwise use the proceeds received by the Issuer from its
sale of the Securities in such a manner as would require the Issuer or any of the Subsidiaries to
register as an investment company under the 1940 Act.
(m) The Issuer will maintain a transfer agent and, if necessary under the jurisdiction of
incorporation of the Issuer, a registrar for the Common Stock.
(n) The Issuer will not take, directly or indirectly, any action designed to or that could
reasonably be expected to cause or result in stabilization or manipulation of the price of the
Securities.
6. Costs and Expenses.
The Issuer will pay all costs, expenses and fees incident to the performance of the
obligations of the Issuer under this Agreement, including, without limiting the generality of the
foregoing, the following: accounting fees of the Issuer; the fees and disbursements of counsel for
the Issuer; the cost of printing and delivering to, or as requested by, the Underwriters copies of
the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus, and any supplements
or amendments thereto; the filing fees of the Commission; the filing fees and expenses (including
legal fees and disbursements) incident to securing any required review by the FINRA of the terms of
the sale of the Securities; the preparation, printing, authentication, issuance and delivery of
certificates representing the Securities, including any stamp or transfer taxes in connection with
the original issuance and sale of the Securities by the Issuer to the Underwriters; the printing
(or reproduction) and delivery of this Agreement and all other agreements or documents approved by
the Issuer and printed (or reproduced) and delivered in connection with the offering of the
Securities; the transportation and other expenses of the Issuer’s officers and employees in
connection with presentations to prospective purchasers of the Securities; the listing fee of The
Nasdaq Stock Market; and all other costs and expenses of the
19
Issuer and its representatives incident to the performance by the Issuer of its obligations
hereunder.
The Issuer shall not, however, be required to pay for any of the Underwriters expenses (other
than those related to qualification under FINRA regulations and state securities or blue sky laws)
except that, if this Agreement shall not be consummated because the conditions in Section 7 hereof
are not satisfied (except Section 7(c)), or by reason of any failure, refusal or inability on the
part of the Issuer to perform any undertaking or satisfy any condition of this Agreement or to
comply with any of the terms hereof on its part to be performed, unless such failure to satisfy
said condition or to comply with said terms be due to the default or omission of any Underwriter,
or by reason of a termination of this Agreement by the Representative as a result of any suspension
of trading of the Common Stock by the Nasdaq Stock Market, the Commission or any governmental
authority as contemplated by Section 13(a)(iv) below arising out of an action or omission of the
Issuer, then the Issuer shall reimburse the several Underwriters for reasonable out-of-pocket
expenses, including all fees and disbursements of counsel, reasonably incurred in connection with
investigating, marketing and proposing to market the Securities or in contemplation of performing
their obligations hereunder; but the Issuer shall not in any event be liable to any of the several
Underwriters for damages on account of loss of anticipated profits from the sale by them of the
Securities.
7. Conditions of Obligations of the Underwriters.
The several obligations of the Underwriters to purchase the Firm Securities on the Closing
Date and the Option Securities, if any, on the Option Closing Date, are subject to the accuracy, as
of the Closing Date and the Option Closing Date, if any, of the representations and warranties of
the Issuer contained herein, and to the performance in all material respects by the Issuer of its
covenants and obligations hereunder and to the following additional conditions:
(a) All post-effective amendments to the Registration Statement filed prior to the Closing
Date or the Option Closing Date, if any, as applicable, shall have become effective and any and all
filings required by Rule 424 and Rule 430B of the Rules and Regulations shall have been made, and
any request of the Commission for additional information (to be included in the Registration
Statement or otherwise) shall have been disclosed to the Representative and complied with to their
reasonable satisfaction. All material required to be filed by the Issuer pursuant to Rule 433(d)
under the Securities Act shall have been filed with the Commission within the applicable time
period prescribed for such filing by Rule 433 under the Securities Act, except for any issuer
information contained in any Offering Participant Free Writing Prospectus. No stop order
suspending the effectiveness of the Registration Statement, as amended from time to time, shall
have been issued and no proceedings for that purpose shall have been taken or, to the knowledge of
the Issuer, shall be contemplated by the Commission; no stop order suspending or preventing the use
of the Prospectus or any Issuer Free Writing Prospectus shall have been initiated or, to the
knowledge of the Issuer, shall be contemplated by the Commission; and no injunction, restraining
order, or order of any nature by a federal or state court of competent jurisdiction shall have been
issued as of the Closing Date which would prevent the issuance of the Securities.
(b) The Representative shall have received on the Closing Date and each Option Closing Date,
if any, the opinions of Xxxxx Xxxxx L.L.P., counsel for the Issuer, and the opinions of
20
the General Counsel of the Issuer, each dated the Closing Date or the Option Closing Date, if
any, addressed to the Underwriters in substantially the form attached hereto as Exhibit C-1 and
Exhibit C-2, respectively.
(c) The Representative shall have received from Xxxxxx & Xxxxxx L.L.P, counsel for the
Underwriters, an opinion dated the Closing Date and the Option Closing Date, if any, the validity
of the Securities and other related matters as the Representative reasonably may request, and such
counsel shall have received such papers and information as they may reasonably request to enable
them to pass upon such matters.
(d) The Representative shall have received, on the date hereof, the Closing Date and the
Option Closing Date, if any, a letter dated the date hereof, the Closing Date or the Option Closing
Date, if any, in form and substance satisfactory to the Representative, from Xxxxxxx Xxxx Xxxxxxx
of Texas, P.C. confirming that they are an independent registered public accounting firm within the
meaning of the Securities Act and the applicable published Rules and Regulations thereunder and
stating that in their opinion the financial statements and schedules examined by them and included
or incorporated by reference in the Registration Statement comply as to form in all material
respects with the applicable accounting requirements of the Securities Act and the related
published Rules and Regulations; and containing such other statements and information as is
ordinarily included in accountants’ “comfort letters” to Underwriters with respect to the financial
statements and certain financial and statistical information contained in the Registration
Statement and the Prospectus.
(e) The Representative shall have received, on the date hereof, the Closing Date and the
Option Closing Date, if any, letters dated the date hereof, the Closing Date or the Option Closing
Date, if any, in form and substance satisfactory to the Representative, from each of the
Independent Petroleum Engineers, in each case confirming the conclusions and findings of such firm
with respect to the oil and natural gas reserves of the Issuer and its Subsidiaries.
(f) The Representative shall have received on the Closing Date and the Option Closing Date, if
any, a certificate or certificates of the Issuer’s Chief Executive Officer and Chief Financial
Officer to the effect that, as of the Closing Date or the Option Closing Date, if any, each of them
severally represents as follows:
(i) The Registration Statement has become effective under the Securities Act and no stop order
suspending the effectiveness of the Registration Statement has been issued, and, to his knowledge,
no proceedings for such purpose have been instituted or are pending;
(ii) The representations and warranties of the Issuer contained in Section 1 hereof are true
and correct as of the Closing Date or the Option Closing Date, if any;
(iii) They have carefully examined the Registration Statement and the Prospectus and, in their
opinion, as of the effective date of the Registration Statement, such Registration Statement and
Prospectus did not include any untrue statement of a material fact and did not omit to state a
material fact required to be stated therein or necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading,
21
and since the effective date of the Registration Statement, no event has occurred which should
have been set forth in a supplement to or an amendment of the Prospectus which has not been so set
forth in such supplement or amendment; and
(iv) Since the respective dates as of which information is given in the Disclosure Package,
except as disclosed in the certificate, (1) there has not been any material adverse change in the
assets, properties, condition, financial or otherwise, or in the results of operations, business
affairs or business prospects of the Issuer and its Subsidiaries considered as a whole, whether or
not arising in the ordinary course of business otherwise than as set forth or contemplated in the
Disclosure Package; and (2) neither the Issuer nor any of its Subsidiaries shall have sustained any
loss or interference with its business from fire, explosion, flood or other calamity, whether or
not covered by insurance, or from any labor dispute or court or governmental action, order or
decree which would have a Material Adverse Effect otherwise than as set forth or contemplated in
the Disclosure Package.
(g) The Issuer shall have furnished to the Representative such further certificates and
documents confirming the representations and warranties, covenants and conditions contained herein
and related matters as the Representative may reasonably have requested.
(h) The Firm Securities and Option Securities, if any, shall have been approved for
designation upon notice of issuance on The Nasdaq Stock Market.
(i) The Lockup Agreements described in Exhibit B shall be in full force and effect.
If any of the conditions hereinabove provided for in this Section shall not have been
fulfilled when and as required by this Agreement to be fulfilled, the obligations of the
Underwriters hereunder may be terminated by the Representative. In such event, the Issuer and the
Underwriters shall not be under any obligation to each other (except to the extent provided in
Sections 9 and 10 hereof).
8. Conditions of the Obligations of the Issuer.
The obligations of the Issuer to sell and deliver the portion of the Securities required to be
delivered as and when specified in this Agreement are subject to the conditions that at the Closing
Date or the Option Closing Date, if any, no stop order suspending the effectiveness of the
Registration Statement shall have been issued and in effect or proceedings therefor initiated or
threatened.
9. QIU Indemnification.
The Issuer will indemnify and hold harmless the QIU, its directors, officers, employees and
agents and each person, if any, who controls the QIU within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act (each, a “QIU Indemnitee”) against any and all
losses, claims, damages or liabilities, joint or several, to which the QIU may become subject,
under the Securities Act, the Exchange Act, other Federal or state statutory law or regulation or
otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof)
arise out of or are based upon the QIU’s acting (or alleged failing to act) as such “qualified
independent
22
underwriter” and will reimburse the QIU for any legal or other expenses reasonably incurred by the
QIU in connection with investigating or defending any such loss, claim, damage, liability or
action, except for any losses, claims, damages, liabilities, and judgments resulting from the QIU
Indemnitee’s willful misconduct.
10. Indemnification.
(a) The Issuer agrees:
(i) to indemnify and hold harmless each Underwriter, its partners, members, directors,
officers, employees, agents and each person, if any, who controls such Underwriter within the
meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (each an “Indemnified
Party”), against any and all losses, claims, damages or liabilities, joint or several, to which
such Indemnified Party may become subject under the Securities Act, the Exchange Act, other Federal
or state statutory law or regulation or otherwise, insofar as such losses, claims, damages or
liabilities (or actions or proceedings in respect thereof) arise out of or are based upon (i) any
untrue statement or alleged untrue statement of any material fact contained in (A) the Registration
Statement, any Preliminary Prospectus, the Prospectus or any amendment or supplement thereto, (B)
any Issuer Free Writing Prospectus or any “issuer information” filed or required to be filed
pursuant to Rule 433(d) (other than any “issuer information” contained in any Offering Participant
Free Writing Prospectus) or (C) any “issuer information” contained in any “road show” (each as
defined in Rule 433 of the Rules and Regulations) not constituting an Issuer Free Writing
Prospectus (such information, a “Non-Prospectus Road Show”) or (ii) the omission or alleged
omission to state therein a material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were made, not misleading;
provided, however, that the Issuer will not be liable in any such case to the extent that any such
loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged
untrue statement, or omission or alleged omission made in the Registration Statement, any
Preliminary Prospectus, the Prospectus, or such amendment or supplement, any Issuer Free Writing
Prospectus or issuer information filed or required to be filed pursuant to Rule 433(d) under the
Securities Act or any Non-Prospectus Road Show in reliance upon and in conformity with written
information furnished to the Issuer by or through the Representative specifically for use in the
preparation thereof, such information being listed in Section 15 below.
(ii) to reimburse each Indemnified Party upon demand for any legal or other out-of-pocket
expenses reasonably incurred by such Indemnified Party in connection with investigating or
defending any such loss, claim, damage or liability, action or proceeding or in responding to a
subpoena or governmental inquiry related to the offering of the Securities, whether or not such
Indemnified Party is a party to any action or proceeding. In the event that it is finally
judicially determined that the Underwriters were not entitled to receive payments for legal and
other expenses pursuant to this subparagraph, the Underwriters will promptly return all sums that
had been advanced pursuant hereto.
(b) Each Underwriter, severally and not jointly, will indemnify and hold harmless the Issuer,
each of its directors and employees, each of its officers who have signed the
23
Registration Statement and each person, if any, who controls the Issuer within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act, against any losses, claims,
damages or liabilities to which the Issuer or any such director, officer or controlling person may
become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or
liabilities (or actions or proceedings in respect thereof) arise out of or are based upon (i) any
untrue statement or alleged untrue statement of any material fact contained in the Registration
Statement, the Prospectus or any amendment or supplement thereto, any Issuer Free Writing
Prospectus or any Offering Participant Free Writing Prospectus (ii) the omission or the alleged
omission to state therein a material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading;
and will reimburse any legal or other expenses reasonably incurred by the Issuer or any such
director, officer or controlling person in connection with investigating or defending any such
loss, claim, damage, liability, action or proceeding; provided, however, that each Underwriter will
be liable in each case to the extent, but only to the extent, that such untrue statement or alleged
untrue statement or omission or alleged omission has been made in the Registration Statement, the
Prospectus or any amendment or supplement thereto, any Issuer Free Writing Prospectus or any
Offering Participant Free Writing Prospectus in reliance upon and in conformity with written
information furnished to the Issuer by or through the Representative specifically for use in the
preparation thereof, such information being listed in Section 15 below.
(c) In case any proceeding (including any governmental investigation) shall be instituted
involving any person in respect of which indemnity may be sought pursuant to Section 9 or this
Section, such person (the “indemnified party”) shall promptly notify the person against whom such
indemnity may be sought (the “indemnifying party”) in writing. No indemnification provided for in
Section 9 or Section 10(a) or (b) shall be available to any party who shall fail to give notice as
provided in this Subsection if the party to whom notice was not given was unaware of the proceeding
to which such notice would have related and was materially prejudiced by the failure to give such
notice, but the failure to give such notice shall not relieve the indemnifying party or parties
from any liability which it or they may have to the indemnified party for contribution or otherwise
than on account of the provisions of Section 9 or Section 10(a) or (b). In case any such
proceeding shall be brought against any indemnified party and it shall notify the indemnifying
party of the commencement thereof, the indemnifying party shall be entitled to participate therein
and, to the extent that it shall wish, jointly with any other indemnifying party similarly
notified, to assume the defense thereof, with counsel reasonably satisfactory to such indemnified
party and shall pay as incurred the fees and disbursements of such counsel related to such
proceeding, and shall not be liable to such indemnified party for any legal or other expenses,
except as provided below and except for the reasonable costs of investigation subsequently incurred
by such indemnified party in connection with the defense thereof. In any such proceeding, any
indemnified party shall have the right to retain its own counsel at its own expense.
Notwithstanding the foregoing, the indemnifying party shall pay as incurred (or within 30 days of
presentation) the fees and expenses of the counsel retained by the indemnified party in the event
(i) the indemnifying party and the indemnified party shall have mutually agreed to the retention of
such counsel, (ii) the named parties to any such proceeding (including any impleaded parties)
include both the indemnifying party and the indemnified party and the indemnified party shall have
reasonably concluded that representation of both parties by the same counsel would be inappropriate
due to actual or potential differing interests between them or (iii) the indemnifying party shall
have failed to assume the defense and employ
24
counsel reasonably acceptable to the indemnified party within a reasonable period of time
after notice of commencement of the action.
It is understood that the indemnifying party shall not, in connection with any proceeding or
related proceedings in the same jurisdiction, be liable for the reasonable fees and expenses of
more than one separate firm for all such indemnified parties. Such firm shall be designated in
writing by the Representative in the case of parties indemnified pursuant to Section 10(a) and by
the Issuer in the case of parties indemnified pursuant to Section 10(b). The indemnifying party
shall not be liable for any settlement effected without its written consent but if settled with
such consent or if there be a final judgment for the plaintiff (other than a final judgment entered
into pursuant to a settlement as to which the indemnifying party did not consent), the indemnifying
party agrees to indemnify the indemnified party from and against any loss or liability by reason of
such settlement or judgment; provided, however, that if at any time an indemnified party shall have
requested an indemnifying party to reimburse the indemnified party for reasonable fees and expenses
of counsel in accordance with the provisions hereof, such indemnifying party agrees that it shall
be liable for any settlement of the nature contemplated by Section 9 or Section 10(a) or (b)
effected without its written consent if (i) such settlement is entered into in good faith by the
indemnified party more than 60 days after receipt by such indemnifying party of the aforesaid
request, (ii) such indemnifying party shall have received notice of the terms of such settlement at
least 45 days prior to such settlement being entered into and (iii) such indemnifying party shall
not have reimbursed such indemnified party in accordance with such request prior to the date of
such settlement. In addition, the indemnifying party will not, without the prior written consent
of the indemnified party, settle or compromise or consent to the entry of any judgment in any
pending or threatened claim, action or proceeding of which indemnification may be sought hereunder
(whether or not any indemnified party is an actual or potential party to such claim, action or
proceeding) unless such settlement, compromise or consent (i) includes an unconditional release of
each indemnified party from all liability arising out of such claim, action or proceeding and (ii)
does not include a statement as to, or an admission of, fault, culpability to act by or on behalf
of an indemnified party.
(d) If the indemnification provided for in this Section is unavailable to or insufficient to
hold harmless an indemnified party under Section 10(a) or (b) above in respect of any losses,
claims, damages or liabilities (or actions or proceedings in respect thereof) referred to therein,
then each indemnifying party shall contribute to the amount paid or payable by such indemnified
party as a result of such losses, claims, damages or liabilities (or actions or proceedings in
respect thereof) in such proportion as is appropriate to reflect the relative benefits received by
the Issuer on the one hand and the Underwriters on the other from the offering of the Securities.
If, however, the allocation provided by the immediately preceding sentence is not permitted by
applicable law then each indemnifying party shall contribute to such amount paid or payable by such
indemnified party in such proportion as is appropriate to reflect not only such relative benefits
but also the relative fault of the Issuer on the one hand and the Underwriters on the other in
connection with the statements or omissions which resulted in such losses, claims, damages or
liabilities, (or actions or proceedings in respect thereof), as well as any other relevant
equitable considerations. The relative benefits received by the Issuer on the one hand and the
Underwriters on the other shall be deemed to be in the same proportion as the total net proceeds
from the offering (before deducting expenses) received by the Issuer bear to the total underwriting
discounts and commissions received by the Underwriters, in each case as set forth in the table on
the cover page of
25
the Prospectus. The relative fault shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information supplied by the Issuer on the one hand or
the Underwriters on the other and the parties’ relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission.
(e) The Issuer and the Underwriters agree that it would not be just and equitable if
contributions pursuant to this Subsection were determined by pro rata allocation (even if the
Underwriters were treated as one entity for such purpose) or by any other method of allocation
which does not take account of the equitable considerations referred to above in this Subsection.
The amount paid or payable by an indemnified party as a result of the losses, claims, damages or
liabilities (or actions or proceedings in respect thereof) referred to above in this Subsection
shall be deemed to include any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any such action or claim. Notwithstanding the
provisions of this Section 10, (i) no Underwriter shall be required to contribute any amount in
excess of the amount by which the total price at which the shares underwritten by it and
distributed to the public were offered to the public exceeds the amount of damages which such
Underwriter has otherwise been required to pay by reason of any such untrue or alleged untrue
statement or omission or alleged omission and (ii) no person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from
any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section
10(e), each person, if any, who controls an Underwriter within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act shall have the same rights to contribution as such
Underwriter, and each director of the Issuer, each officer of the Issuer who signed the
Registration Statement, and each person, if any, who controls the Issuer within the meaning of the
Section 15 of the Securities Act or Section 20 of the Exchange Act, shall have the same rights to
contribution as the Issuer. Any party entitled to contribution will, promptly after receipt of
notice of commencement of any action, suit or proceeding against such party in respect of which a
claim for contribution may be made against another party or parties under this Section 10(e),
notify in writing such party or parties from whom contribution may be sought, but the omission so
to notify such party or parties from whom contribution may be sought shall not relieve the party or
parties from whom contribution may be sought from any other obligation it or they may have
hereunder or otherwise than under this Section 10(e). No party shall be liable for contribution
with respect to any action, suit, proceeding or claim settled without its written consent. The
Underwriters’ obligations in this Subsection to contribute are several in proportion to their
respective underwriting obligations and not joint.
(f) The indemnity and contribution agreements contained in this Section 10 and Section 9 and
the representations and warranties of the Issuer set forth in this Agreement shall remain operative
and in full force and effect, regardless of (i) any investigation made by or on behalf of any
Underwriter or any person controlling any Underwriter, the Issuer, its directors or officers or any
persons controlling the Issuer, (ii) acceptance of any Shares and payment therefor hereunder, and
(iii) any termination of this Agreement. A successor to any Underwriter, or to the Issuer, its
directors or officers, or any person controlling the Issuer, shall be entitled to the benefits of
the indemnity, contribution and reimbursement agreements contained in this Section 10 and Section
9.
26
11. Default by Underwriters
If on the Closing Date or the Option Closing Date, if any, any Underwriter shall fail to
purchase and pay for the portion of the Securities which such Underwriter has agreed to purchase
and pay for on such date (otherwise than by reason of any default on the part of the Issuer), you,
as the Representative of the Underwriters, shall use your reasonable efforts to procure within 36
hours thereafter one or more of the other Underwriters, or any others, to purchase from the Issuer
such amounts as may be agreed upon and upon the terms set forth herein, the Firm Securities or
Option Securities, as the case may be, which the defaulting Underwriter or Underwriters failed to
purchase. If, however, the Representative shall not have completed such arrangements within such
36-hour period, then the Issuer shall be entitled to a further period of 36 hours within which to
procure another party or other parties satisfactory to the Underwriters to purchase such Securities
on such terms. After giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by the Representative and the Issuer as provided above, if
during such 36 hours the Representative shall not have procured such other Underwriters, or any
others, to purchase the Firm Securities or Option Securities, as the case may be, agreed to be
purchased by the defaulting Underwriter or Underwriters, then (a) if the aggregate principal
amount of Securities with respect to which such default shall occur does not exceed 10% of the
aggregate principal amount of all Firm Securities or Option Securities, as the case may be, covered
hereby, the other Underwriters shall be obligated, severally, in proportion to the respective
principal amount of Firm Securities or Option Securities, as the case may be, which they are
obligated to purchase hereunder, to purchase the Firm Securities or Option Securities, as the case
may be, which such defaulting Underwriter or Underwriters failed to purchase, or (b) if the
aggregate principal amount of Firm Securities or Option Securities, as the case may be, with
respect to which such default shall occur exceeds 10% of the principal amounts of Firm Securities
or Option Securities, as the case may be, covered hereby, the Issuer or the Representative will
have the right to terminate this Agreement without liability on the part of the
non-defaulting Underwriters or of the Issuer except to the extent provided in Section 9 or Section 10 hereof. In the event of a default by any Underwriter or Underwriters, as set forth in this Section, the Closing Date or Option Closing Date, if any, may be postponed for such period, not exceeding seven days, as you, as the Representative or the Issuer, may determine in order that the required changes in the Registration Statement or in the Prospectus or in any other documents or arrangements may be effected. The term “Underwriter” includes any person substituted for a defaulting Underwriter. Any action taken under this Section shall not relieve any defaulting Underwriter from liability in respect of any default of such Underwriter under this Agreement.
non-defaulting Underwriters or of the Issuer except to the extent provided in Section 9 or Section 10 hereof. In the event of a default by any Underwriter or Underwriters, as set forth in this Section, the Closing Date or Option Closing Date, if any, may be postponed for such period, not exceeding seven days, as you, as the Representative or the Issuer, may determine in order that the required changes in the Registration Statement or in the Prospectus or in any other documents or arrangements may be effected. The term “Underwriter” includes any person substituted for a defaulting Underwriter. Any action taken under this Section shall not relieve any defaulting Underwriter from liability in respect of any default of such Underwriter under this Agreement.
12. Notices.
All communications hereunder shall be in writing and, except as otherwise provided herein,
will be mailed, delivered, or faxed and confirmed as follows:
if to the Underwriters, to: | Credit Suisse Securities (USA) LLC | |||
Eleven Xxxxxxx Xxxxxx | ||||
Xxx Xxxx, Xxx Xxxx 00000-0000 | ||||
Attention: LCO-IBD | ||||
Fax: (000) 000-0000 |
27
with a copy (which shall not constitute notice) to: | ||||
Xxxxxx & Xxxxxx L.L.P. | ||||
0000 Xxxxxx, Xxxxx 0000 | ||||
Xxxxxxx, Xxxxx 00000 | ||||
Attention: Xxxxx X. Xxxxxx | ||||
Fax: (000) 000-0000 | ||||
if to the QIU to: | RBC Capital Markets Corporation | |||
c/o RBC Capital Markets | ||||
Xxx Xxxxxxx Xxxxx, 000 Xxxxxxxx | ||||
Xxx Xxxx, XX 00000-0000 | ||||
Attention: Xxx Xxxxx | ||||
Syndicate Director | ||||
Fax: (000) 000-0000 | ||||
if to the Issuer, to: | Carrizo Oil & Gas, Inc. | |||
0000 Xxxxxxxxx Xxxxxx, Xxxxx 0000 | ||||
Xxxxxxx, Xxxxx 00000 | ||||
Attention: Xxxxxx X. Xxxxxx | ||||
General Counsel | ||||
Fax: (000) 000-0000 | ||||
with a copy (which shall not constitute notice) to: | ||||
Xxxxx Xxxxx L.L.P. | ||||
Xxx Xxxxx Xxxxx | ||||
000 Xxxxxxxxx | ||||
Xxxxxxx, Xxxxx 00000 | ||||
Attention: Xxxx X. Xxxxxx | ||||
Fax: (000) 000-0000 |
13. Termination. This Agreement may be terminated by the Representative at any
time prior to the Closing Date:
(a) if any of the following has occurred: (i) since the respective dates as of which
information is given in the Registration Statement and the Prospectus, any change, or any
development or event involving a prospective change, in the condition (financial or otherwise),
results of operations, business or properties of the Issuer and its subsidiaries taken as a whole,
which, in the judgment of the Representative, is material and adverse and makes it impractical or
inadvisable to market and deliver the Securities as contemplated in the Prospectus; (ii) any change
in U.S. or international financial, political or economic conditions the effect of which is such as
to make it, in the judgment of the Representative, impractical to market or to enforce contracts
for the sale of the Securities, whether in the primary market or in respect of dealings in the
secondary
market; (iii) any suspension or material limitation of trading in securities generally on The
Nasdaq Stock Market, or any setting of minimum prices for trading on such exchange; (iv) any
suspension
28
of trading of any securities of the Issuer on any exchange or in the over-the-counter
market; (v) any banking moratorium declared by any
U.S. federal or New York state authorities; (vi) any major disruption of settlements of securities, payment, or clearance services in the United States or any other country where such securities are listed or (vii) any attack on, outbreak or escalation of hostilities or act of terrorism involving the United States, except as existing with similar severity on the date hereof involving the United States, any declaration of war by Congress or any other national or international calamity or emergency if, in the judgment of the Representative, the effect of any such attack, outbreak, escalation, act, declaration, calamity or emergency is such as to make it impractical or inadvisable to market and deliver the Securities or to enforce contracts for the sale of the Securities; or
U.S. federal or New York state authorities; (vi) any major disruption of settlements of securities, payment, or clearance services in the United States or any other country where such securities are listed or (vii) any attack on, outbreak or escalation of hostilities or act of terrorism involving the United States, except as existing with similar severity on the date hereof involving the United States, any declaration of war by Congress or any other national or international calamity or emergency if, in the judgment of the Representative, the effect of any such attack, outbreak, escalation, act, declaration, calamity or emergency is such as to make it impractical or inadvisable to market and deliver the Securities or to enforce contracts for the sale of the Securities; or
(b) as provided in Sections 7 and 11 of this Agreement.
14. Successors.
This Agreement has been and is made solely for the benefit of the Issuer and Underwriters and
their respective successors, executors, administrators, heirs and assigns, and the officers,
directors and controlling persons referred to herein, and no other person will have any right or
obligation hereunder. No purchaser of any of the Securities from any Underwriter shall be deemed a
successor or assign merely because of such purchase.
15. Information Provided by Underwriters.
The Issuer and the Underwriters acknowledge and agree that the only information furnished or
to be furnished by any Underwriter to the Issuer for inclusion in the Prospectus, any Issuer Free
Writing Prospectus or the Registration Statement consists of the information contained in the
fourth, sixth, tenth, eleventh, twelfth, thirteenth, fourteenth, fifteenth and sixteenth paragraphs
under the caption “Underwriting” in the Prospectus and, with respect to each Underwriter, severally
but not jointly, any information contained in any Offering Participant Free Writing Prospectus
distributed or otherwise used in connection with the offering of the Securities by that
Underwriter.
16. Research Independence.
In addition, the Issuer acknowledges that the Underwriters’ research analysts and research
departments are required to be independent from their respective investment banking divisions and
are subject to certain regulations and internal policies, and that such Underwriters’ research
analysts may hold and make statements or investment recommendations and/or publish research reports
with respect to the Issuer and/or the offering that differ from the views of its investment
bankers. The Issuer hereby waives and releases, to the fullest extent permitted by law, any claims
that the Issuer may have against the Underwriters with respect to any conflict of interest that may
arise from the fact that the views expressed by their independent research analysts and research
departments may be different from or inconsistent with the views or advice communicated to the
Issuer by such Underwriters’ investment banking divisions. The Issuer acknowledges that each of
the Underwriters is a full service securities firm and as such from time
to time, subject to applicable securities laws, may effect transactions for its own account or
the
29
account of its customers and hold long or short position in debt or equity securities of the
companies which may be the subject to the transactions contemplated by this Agreement.
17. No Fiduciary Duty
Notwithstanding any preexisting relationship, advisory or otherwise, between the parties or
any oral representations or assurances previously or subsequently made by the underwriters, the
Issuer acknowledges and agrees that:
(a) nothing herein shall create a fiduciary or agency relationship between the Issuer and the
Underwriters;
(b) the Underwriters are not acting as advisors, expert or otherwise, to the Issuer in
connection with this offering, sale of the Securities or any other services the Underwriters may be
deemed to be providing hereunder, including, without limitation, with respect to the public
offering price of the Securities;
(c) the relationship between the Issuer and the Underwriters is entirely and solely
commercial, based on arms-length negotiations;
(d) any duties and obligations that the Underwriters may have to the Issuer shall be limited
to those duties and obligations specifically stated herein; and
The Issuer hereby waives and releases, to the fullest extent permitted by law, any claims that
the Issuer may have against the Underwriters with respect to any breach or alleged breach of
fiduciary duty in connection with the offering of the Securities.
18. Miscellaneous.
This Agreement may be executed in counterparts, each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument.
This Agreement shall be governed by, and construed in accordance with, the laws of the State
of New York. The Issuer hereby submits to the non-exclusive jurisdiction of the Federal and state
courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of
or relating to this Agreement or the transactions contemplated hereby. The Issuer irrevocably and
unconditionally waives any objection to the laying of venue of any suit or proceeding arising out
of or relating to this Agreement or the transactions contemplated hereby in Federal and state
courts in the Borough of Manhattan in The City of New York and irrevocably and unconditionally
waives and agrees not to plead or claim in any such court that any such suit or proceeding in any
such court has been brought in an inconvenient forum.
This Agreement, together with all other written agreements of the parties executed on the date
hereof in connection with the offering of the Securities, constitutes the entire agreement of the
parties to this Agreement and supersedes all prior written or oral and all contemporaneous oral
agreements, understandings and negotiations with respect to the subject matter hereof.
30
This Agreement may only be amended or modified in writing, signed by all of the parties
hereto, and no condition herein (express or implied) may be waived unless waived in writing by each
party whom the condition is meant to benefit.
[Remainder of page intentionally blank]
31
If the foregoing letter is in accordance with your understanding of our agreement, please sign
and return to us the enclosed duplicates hereof, whereupon it will become a binding agreement among
the Issuer and the several Underwriters in accordance with its terms.
Very truly yours, | ||||||
CARRIZO OIL & GAS, INC. | ||||||
By | /s/ X.X. Xxxxxxx, XX
|
|||||
President and Chief Executive Officer |
The foregoing Underwriting Agreement is hereby confirmed
and accepted as of the date first above written.
For Itself and as the Representative of
the several Underwriters listed on Schedule I
CREDIT SUISSE SECURITIES (USA) LLC
By: Name: |
/s/ Xxxxx Xxxxx
|
|||
Title:
|
Director |
As qualified independent underwriter
RBC CAPITAL MARKETS CORPORATION
By: Name: |
/s/ Xxxxxxx Xxxxxxxxxxx
|
|||
Title:
|
Managing Director |
32
Schedule I
Schedule of Underwriters
Principal | ||||
Amount of | ||||
Firm | ||||
Securities to | ||||
Underwriter | be Purchased | |||
Credit Suisse Securities (USA) LLC |
$ | 182,000,000 | ||
RBC Capital markets Corporation |
78,000,000 | |||
X.X. Xxxxxx Securities, Inc. |
32,500,000 | |||
UBS Securities LLC |
32,500,000 | |||
Total |
$ | 325,000,000 | ||
Schedule I
Schedule II
None.
Schedule II
Schedule III
Terms
Issuer Free Writing Prospectus dated May 21, 2008 to
Preliminary Prospectus Supplement dated May 21, 2008
to Prospectus dated May 21, 2008
Registration Statement No. 333-142346
Filed Pursuant to Rule 433
Preliminary Prospectus Supplement dated May 21, 2008
to Prospectus dated May 21, 2008
Registration Statement No. 333-142346
Filed Pursuant to Rule 433
Carrizo Oil & Gas, Inc.
$325,000,000
4.375% Convertible Senior Notes due 2028
This term sheet relates only to the securities described below and should be read together with the
preliminary prospectus supplement and related base prospectus, each dated May 21, 2008 (together,
the “Preliminary Prospectus”) (including the documents incorporated by reference therein), relating
to the securities before making a decision in connection with an investment in the securities. The
information in this term sheet supersedes the information in the Preliminary Prospectus to the
extent that it is inconsistent therewith. Terms used but not defined herein have the meanings
ascribed to them in the Preliminary Prospectus.
Issuer: |
Carrizo Oil & Gas, Inc. (Nasdaq GSM: CRZO) | |
Last sale price of CRZO common stock: |
$67.84 (May 21, 2008) | |
Aggregate principal amount offered: |
$325 million | |
Additional purchase option: |
30-day option, $48.75 million | |
Issue price: |
100% | |
Underwriting discounts and net
proceeds: |
Per Note | Total | |||||||||||||||
Without | With | Without | With | |||||||||||||
Over-allotment | Over-allotment | Over-allotment | Over-allotment | |||||||||||||
Underwriting discounts and
commissions |
2.25 | % | 2.25 | % | $ | 7,312,500 | $ | 8,409,375 | ||||||||
Proceeds to Issuer
(before expenses) |
97.75 | % | 97.75 | % | $ | 317,687,500 | $ | 365,340,625 |
Selling concession:
|
1.350% of the principal amount per note | |
Annual interest rate:
|
4.375% per year, accruing from May 28, 2008 | |
Maturity date:
|
June 1, 2028 | |
Interest payment dates:
|
June 1 and December 1 of each year, beginning December 1, 2008 | |
Record dates:
|
May 15 and November 15 of each year |
Schedule III
Conversion price:
|
Initially approximately $100.06 | |
Conversion rate:
|
Initially 9.9936 shares of common stock per $1,000 principal amount of notes (subject to adjustment) | |
CUSIP/ISIN:
|
000000XX0/US144577AA15 | |
Repurchase Dates at Option of
Holder:
|
June 1, 2013, 2018 and 2023 or upon a fundamental change (as described in the Preliminary Prospectus) | |
Redemption Date at Issuer’s Option:
|
Any time on or after June 1, 2013 | |
Adjustment to conversion rate upon
a fundamental change:
|
Holders who convert their notes in connection with a fundamental change that occurs on or prior to June 1, 2013 are entitled to an increase in the conversion rate for notes surrendered for conversion in connection with such fundamental change. The following table sets forth the stock price, effective date and number of additional shares to be added to the conversion rate. |
Number of Additional Shares
Stock Price | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Effective Date |
$ | 67.84 | $ | 70.00 | $ | 75.00 | $ | 80.00 | $ | 85.00 | $ | 90.00 | $ | 95.00 | $ | 100.00 | $ | 105.00 | $ | 110.00 | $ | 115.00 | $ | 120.00 | $ | 125.00 | $ | 130.00 | $ | 135.00 | $ | 140.00 | $ | 145.00 | $ | 150.00 | $ | 160.00 | $ | 170.00 | $ | 180.00 | $ | 190.00 | ||||||||||||||||||||||||||||||||||||||||||||
May 22, 2008 |
4.7470 | 4.4876 | 3.9626 | 3.5249 | 3.1567 | 2.8446 | 2.5781 | 2.3490 | 2.1508 | 1.9783 | 1.8274 | 1.6947 | 1.5774 | 1.4731 | 1.3801 | 1.2968 | 1.2218 | 1.1541 | 1.0369 | 0.9392 | 0.8568 | 0.7865 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
June 1, 2009 |
4.7470 | 4.3892 | 3.8300 | 3.3667 | 2.9797 | 2.6544 | 2.3790 | 2.1445 | 1.9436 | 1.7706 | 1.6207 | 1.4902 | 1.3761 | 1.2758 | 1.1872 | 1.1086 | 1.0387 | 0.9761 | 0.8692 | 0.7818 | 0.7092 | 0.6481 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
June 1, 2010 |
4.7470 | 4.3650 | 3.6808 | 3.1815 | 2.7681 | 2.4239 | 2.1359 | 1.8935 | 1.6887 | 1.5148 | 1.3663 | 1.2391 | 1.1295 | 1.0347 | 0.9523 | 0.8804 | 0.8173 | 0.7618 | 0.6690 | 0.5953 | 0.5356 | 0.4865 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
June 1, 2011 |
4.7470 | 4.3407 | 3.5095 | 2.9566 | 2.5031 | 2.1302 | 1.8230 | 1.5692 | 1.3590 | 1.1845 | 1.0391 | 0.9177 | 0.8160 | 0.7304 | 0.6581 | 0.5968 | 0.5446 | 0.4999 | 0.4283 | 0.3743 | 0.3327 | 0.2999 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
June 1, 2012 |
4.7470 | 4.3164 | 3.4246 | 2.6590 | 2.1348 | 1.7111 | 1.3707 | 1.0988 | 0.8829 | 0.7123 | 0.5779 | 0.4724 | 0.3897 | 0.3252 | 0.2746 | 0.2350 | 0.2040 | 0.1796 | 0.1449 | 0.1225 | 0.1074 | 0.0968 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
June 1, 2013 |
4.7470 | 4.2921 | 3.3397 | 2.5064 | 1.7711 | 1.1175 | 0.5327 | 0.0064 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
The exact stock price and effective date may not be set forth on the table, in which case:
• | if the stock price is between two stock price amounts on the table above or the effective date is between two effective dates on the table, the number of additional shares will be determined by a straight-line interpolation between the number of additional shares set forth for the higher and lower stock price amounts and the earlier and later effective dates based on a 365-day year, as applicable; | ||
• | if the stock price is in excess of $190.00 per share of common stock (subject to adjustment), the conversion rate of the notes will not be increased by any additional shares; and | ||
• | if the stock price is less than $67.84 per share of common stock (subject to adjustment), the conversion rate of the notes will not be increased by any additional shares. |
Notwithstanding the foregoing, in no event will the total number of shares issuable upon conversion
of a note exceed 14.7406 per $1,000 principal amount of notes, subject to adjustment in the same
manner as the conversion rate as set forth under “— Conversion Rate Adjustments” in the Preliminary
Prospectus.
Other Offering Information
|
||
Trade date:
|
May 21, 2008 | |
Settlement date:
|
May 28, 2008 | |
Use of Proceeds:
|
The Issuer’s net proceeds, before offering expenses, from this offering will be approximately $317.7 million (or $365.3 million, assuming full exercise of the underwriters’ option to |
Schedule III
purchase additional notes). The Issuer expects to use approximately $221.0 million of these proceeds to repay in full all outstanding amounts under its second lien facility, together with associated prepayment penalties. The Issuer expects to use the remaining net proceeds, including any proceeds from the exercise of the underwriters’ option to purchase additional notes, to fund, in part, its increased capital expenditure program for 2008, including its drilling and land acquisition programs in the Xxxxxxx Shale, the Marcellus Shale and elsewhere, and for other corporate purposes. Pending the partial funding of its capital expenditure program, the Issuer intends to use a portion of the remaining net proceeds to repay all of the $70.0 million of borrowings outstanding under its revolving credit facility. | ||
Capitalization:
|
The offering was upsized from an original principal amount of $275,000,000. As a result of this upsize, under “Capitalization” in the Preliminary Prospectus, the Issuer’s as adjusted cash and cash equivalents will be $121,144,000, its as adjusted long-term debt will be $325,000,000 and its as adjusted total capitalization will be $760,144,000. | |
Joint book-running managers:
|
Credit Suisse Securities (USA) LLC RBC Capital Markets Corporation |
|
Co-managers:
|
X.X. Xxxxxx Securities Inc. UBS Securities LLC |
The Issuer has filed a registration statement (including a prospectus) with the SEC for the
offering to which this communication relates. Before you invest, you should read the prospectus in
that registration statement and other documents the Issuer has filed with the SEC for more complete
information about the Issuer and this offering. You may get these documents for free by visiting
XXXXX on the SEC Web site at xxx.xxx.xxx. Alternatively, the Issuer, any underwriter or any dealer
participating in the offering will arrange to send you the prospectus if you request it by calling
Credit Suisse Securities (USA) LLC toll-free at 1-800-221-1037.
ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND
SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT
OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.
Schedule III
Exhibit A
List of Subsidiaries
The Issuer has the following wholly owned subsidiaries:
CCBM, Inc.
CLLR, Inc.
Hondo Pipeline, Inc.
CLLR, Inc.
Hondo Pipeline, Inc.
The Issuer also has an approximate 8.4% interest in the following entity:
Pinnacle Gas Resources, Inc. (Pinnacle shall not be deemed a “Subsidiary” for purposes of this
Agreement)
Exhibit A
Exhibit B
Form of Lock-Up Letter Agreement
Carrizo OIL & GAS, INC.
Carrizo OIL & GAS, INC.
May 21, 2008
Credit
Suisse (USA) LLC
As the Representative of the several underwriters
c/o
|
Credit Suisse Securities (USA) LLC, | |
Eleven Madison Avenue, | ||
New York, N.Y. 10010-3629 |
Ladies and Gentlemen:
This Lock-Up Letter Agreement is being delivered to you in connection with the Underwriting
Agreement (the “Underwriting Agreement”) entered into by Carrizo Oil & Gas, Inc. (the “Issuer”) and
you, as the Representative of the several underwriters, with respect to the public offering (the
“Offering”) of 4.375% of Convertible Senior Notes due 2028
(the “Securities”).
The undersigned agrees that, for the period specified in the following paragraph (the “Lock-Up
Period”), the undersigned will not, without your prior written consent, (i) sell, offer to sell,
contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise dispose
of or agree to dispose of, directly or indirectly, or file (or participate in the filing of) a
registration statement with the Securities and Exchange Commission (the “Commission”) in respect
of, or establish or increase a put equivalent position or liquidate or decrease a call equivalent
position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, and
the rules and regulations of the Commission promulgated thereunder with respect to, any debt
securities or Common Stock of the Issuer or any securities convertible into or exercisable or
exchangeable for Common Stock, or warrants or other rights to purchase Common Stock, (ii) enter
into any swap or other arrangement that transfers to another, in whole or in part, any of the
economic consequences of ownership of debt securities or Common Stock or any securities convertible
into or exercisable or exchangeable for Common Stock, or warrants or other rights to purchase
Common Stock, whether any such transaction is to be settled by delivery of Common Stock or such
other securities, in cash or otherwise, or (iii) publicly announce an intention to effect any
transaction specified in clause (i) or (ii). The foregoing sentence shall not apply to (a) bona
fide gifts, provided the recipient thereof agrees in writing with you to be bound by the terms of
this Lock-Up Letter Agreement, (b) dispositions to any trust for the direct or indirect benefit of
the undersigned and/or the immediate family of the undersigned, provided that such trust agrees in
writing with you to be bound by the terms of this Lock-Up Letter Agreement, (c) shares of Common
Stock subject to bona fide pledges of securities either existing on the date of the lock-up
agreement or subsequently entered, if in the latter case the pledgee of such securities agrees in
writing to be bound by the transfer restrictions contained in the lock-up agreement with respect to
such securities, (d) any sales or option exercises pursuant to Rule 10b5-1 trading plans in effect
as of
Exhibit B-1
the date of the Underwriting Agreement, (e) a number of shares of Common Stock equal to 50% of
the number of shares of restricted stock granted to the undersigned that vest during the Lock-Up
Period or (f) sales of shares of Common Stock under any Rule 10b5-1 trading plan to provide funds
for the satisfaction of anticipated tax liabilities in contemplation of the vesting of restricted
stock during the 70 days following the date of the Underwriting Agreement. The undersigned further
agrees that, during the Lock-Up Period, the undersigned will not, without your prior written
consent, make any demand for, or exercise any right with respect to, the registration of Common
Stock of the Issuer or any securities convertible into or exercisable or exchangeable for Common
Stock, or warrants or other rights to purchase Common Stock.
The initial Lock-Up Period will commence on the date of this Lock-Up Letter Agreement and
continue and include the date 60 days after the public offering date set forth on the final
prospectus supplement used to sell the Securities (the “Public Offering Date”) pursuant to the
Underwriting Agreement, to which you are or expect to become parties.
The undersigned hereby acknowledges and agrees that, prior to engaging in any transaction or
taking any other action that is subject to the terms of this Lock-Up Letter Agreement during the
period from the date of this Lock-Up Letter Agreement to and including the 34th day following the
expiration of the initial Lock-Up Period, it will give notice thereof to the Issuer and will not
consummate such transaction or take any such action unless it has received written confirmation
from the Issuer that the Lock-Up Period (as may have been extended pursuant to the previous
paragraph) has expired.
Notwithstanding anything to the contrary herein, the foregoing restrictions shall not apply to
any transactions effected pursuant to a trading plan entered into by the undersigned pursuant to
Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, prior to the date hereof, and
nothing herein shall prevent the undersigned from entering into one or more 10b5-1 trading plans or
amending one or more existing 10b5-1 trading plans as long as there are no sales of the Issuer’s
common stock under such plans during the Restricted Period.
If (i) the Issuer notifies you in writing that it does not intend to proceed with the
Offering, or (ii) for any reason the Underwriting Agreement shall be terminated prior to the
Closing Date (as defined in the Underwriting Agreement), this Lock-Up Letter Agreement shall be
terminated and the undersigned shall be released from its obligations hereunder.
Yours very truly, | ||||
Exhibit B-2
Exhibit C-1
Form of Opinion of Xxxxx Xxxxx L.L.P.
1. The Issuer is a corporation duly incorporated, validly existing and in good standing under
the laws of the State of Texas. The Issuer has all necessary corporate power and authority to own,
lease and operate its properties and to conduct its business as it is now being conducted and as
such business is described in the Registration Statement, Disclosure Package and Prospectus
Supplement.
2. The Issuer has all requisite corporate power and authority to enter into and perform its
obligations under the Agreement and to issue and sell the Securities.
3. The Agreement has been duly authorized and validly executed and delivered by the Issuer.
4. The Indenture has been duly authorized, executed and delivered and has been duly qualified
under the Trust Indenture Act; the Securities delivered on such Closing Date have been duly
authorized, executed, authenticated, issued and delivered; and the Indenture and the Securities
delivered on such Closing Date constitute valid and legally binding obligations of the Issuer
enforceable against the Issuer in accordance with their terms, except as the enforceability thereof
may be subject to bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and
other laws of general applicability relating to or affecting creditors’ rights and to general
principles of equity and public policy (regardless of whether enforcement is sought in a proceeding
at law or in equity) and to the discretion of the court before which any proceeding may be brought.
5. The Underlying Shares have been duly authorized and reserved for issuance upon such
conversion. The Underlying Shares, when issued and delivered by the Issuer against payment of the
consideration set forth therein will be validly issued, fully paid and nonassessable.
6. The execution and delivery by the Issuer of the Agreement and the consummation of the
transactions provided for therein do not and will not with the passage of time (a) result in a
breach or violation of any of the terms or provisions of, or constitute a default under the
Articles of Incorporation or Bylaws of the Issuer; (b) to our knowledge, result in any breach or
violation of any terms, provisions or conditions of, or constitute a default of or result in the
creation of any lien, charge or encumbrance upon any property or assets of the Issuer pursuant to
any indenture, mortgage, deed of trust, note, contract, commitment, instrument or document filed as
exhibits to the Issuer’s Form 10-K for the fiscal year ended December 31, 2006, as filed with the
SEC on April 2, 2007, Form 10-Q for the quarter ended March 31, 2007, as filed with the SEC on May
9, 2007, Form 10-Q for the quarter ended June 30, 2007, as filed with the SEC on August 8, 2007,
Form 10-Q for the quarter ended September 30, 2007, as amended, as filed with the SEC on November
9, 2007 and amended on January 31, 2008 or Form 10-Q for the quarter ended March 31, 2008, as
amended, as filed with the SEC on May 8, 2008 and amended on May 9, 2008, or Form 10-K for the year
ended December 31, 2007, as filed with the SEC on February 29, 2008 (the “Material Agreements”),
except for such contracts for which
Exhibit C-1
consents or waivers have been obtained as of the date hereof; or (c) to our knowledge, result
in a violation by the Issuer of any law, statute, rule or regulation of the United States or the
State of Texas applicable to the Issuer; which, in the case of either (b) or (c), breach,
violation, default or creation of a lien, charge or encumbrance would, singularly or in the
aggregate, be reasonably expected to have a material adverse effect on the business and operations
of the Issuer or on its legal ability to perform its obligations under the Agreement.
7. No consent, approval or authorization of, filing with, any governmental authority or agency
of the United States or the State of Texas is required on the part of the Issuer as a condition to
the Issuer’s valid execution, delivery and performance of its obligations under the Agreement, or
to the offer, sale or issuance of the Securities by the Issuer other than those that have been made
or obtained under the Securities Act, the Trust Indenture Act and the Rules and Regulations or the
filing of a Prospectus Supplement or any issuer information contained in any Offering Participant
Free Writing Prospectus on a timely basis with the Commission or as may be required under state
securities or “blue sky” laws or by the Nasdaq Stock Market in connection with the sale of the
Securities and except for any Form 8-K filing.
8. The statements in the most recent Preliminary Prospectus and the Prospectus under the
captions “Description of Notes,” “Description of Debt Securities,” “Description of Capital Stock”
insofar as such statements constitute a summary of the terms of the Securities and the Common Stock
are accurate summaries of the terms of the Securities and Common Stock, in all material respects.
9. The Registration Statement, the most recent Preliminary Prospectus and the Prospectus and
the Prospectus Supplement (except for (i) the financial statements and schedules contained therein
or omitted therefrom (including the notes thereto and the auditor’s report thereon), (ii) the
summary reserve reports of each of the Independent Petroleum Engineers included therein, (iii) the
other accounting, financial, statistical or reserve engineering data contained therein or omitted
therefrom or (iv) the exhibits thereto, as to which we have not been asked to comment) appear on
their faces to comply as to form in all material respects with the requirements of the Securities
Act and the Rules and the documents incorporated by reference in the Registration Statement and the
Prospectuses (except for (i) the financial statements and schedules contained therein or omitted
therefrom (including the notes thereto and the auditor’s report thereon), (ii) the summary reserve
reports of each of the Independent Petroleum Engineers included therein, (iii) the other
accounting, financial, statistical or reserve engineering data contained therein or omitted
therefrom or (iv) the exhibits thereto, as to which we have not been asked to comment) when they
become effective or were filed with the Commission, as the case may be, appeared on their faces to
comply as to form in all material respects with the requirements of the Securities Act or the
Exchange Act, as applicable, and the rules and regulations of the Commission thereunder (excluding
those portions of filings which have been amended in subsequent filings made prior to the date
hereof).
10. The Registration Statement became effective under the Securities Act as of the date it was
filed with the Commission. Any required filing of the Preliminary Prospectus and the Prospectus
and any supplement thereto pursuant to Rule 424(b) under the Securities Act has been made in the
manner and within the time period required by such Rule 424(b).
Exhibit C-1
11. The Issuer is not an “investment company” or an entity controlled by an “investment
company” as such terms are defined in the Investment Company Act of 1940, as amended.
12. The statements in the most recent Preliminary Prospectus and the Prospectus under the
caption “Material U.S. Federal Income and Estate Tax Considerations,” insofar as such statements
purport to constitute a summary of provisions of law, are accurate in all material respects with
respect to the matters referred to therein.
We have participated in conferences with officers and other representatives of the Issuer,
your Representative, your counsel and representatives of the independent registered public
accounting firm of the Issuer at which conferences the contents of the Registration Statement, the
Prospectus and the Disclosure Package and related matters were discussed and, although we did not
independently verify such information and are not passing upon and do not assume any responsibility
for the accuracy, completeness or fairness of the statements contained in the Registration
Statement, the Prospectus and the Disclosure Package, we advise you that on the basis of the
foregoing (relying as to materiality to the extent we deem appropriate upon factual statements of
officers and other representatives of the Issuer and your representatives), in the course of acting
as counsel to the Issuer in this transaction, no facts have come to our attention which lead us to
believe that (A) the Registration Statement (except for (i) the financial statements and schedules
contained therein or omitted therefrom (including the notes thereto and the auditor’s report
thereon), (ii) the summary reserve reports of each of the Issuer’s independent petroleum engineers
included therein, (iii) the other accounting, financial, statistical or reserve engineering data
contained therein or omitted therefrom or (iv) the exhibits thereto including the Form T-1) at its
latest Effective Date contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary to make the statements therein not
misleading, or (B) the Prospectus as amended or supplemented (except for (i) the financial
statements and schedules contained therein or omitted therefrom (including the notes thereto and
the auditor’s report thereon), (ii) the summary reserve reports of each of the Issuer’s independent
petroleum engineers included therein or (iii) the other accounting, financial, statistical or
reserve engineering data contained therein or omitted therefrom, as to which we have not been asked
to comment) on the date thereof contained any untrue statement of a material fact or omitted to
state a material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading, or (C) the Disclosure Package (except for (i) the
financial statements and schedules contained therein or omitted therefrom (including the notes
thereto and the auditor’s report thereon), (ii) the summary reserve reports of each of the Issuer’s
independent petroleum engineers included therein or (iii) the other accounting, financial,
statistical or reserve engineering data contained therein or omitted therefrom, as to which we have
not been asked to comment) as of the Applicable Time contained any untrue statement of a material
fact or omitted to state a material fact necessary to make the statements therein, in the light of
the circumstances under which they were made, not misleading.
In connection with our opinion expressed above in paragraph 6, we have reviewed only the
Material Agreements and our opinion is limited in all respects to such review.
Exhibit C-1
As to the opinions expressed above in paragraph 1 as to the existence and good standing of the
Issuer, we have relied solely upon certificates issued by the Office of the Secretary of State of
Texas and the Office of the Comptroller of the State of Texas.
We express no opinion with respect to the legality, validity, binding nature or enforceability
of any provisions of the Agreements (i) purporting to release or exculpate any party from liability
for the acts or omissions of such party proximately causing damages or injuries as result of such
party’s negligence, willful misconduct or strict liability, or purporting to impose a duty upon any
party to indemnify, or make contribution to, any other party when any claimed damages or liability
result from the negligence, strict liability, willful misconduct of, or the violation of federal or
state securities or anti-fraud laws by, the party seeking such indemnity or contribution, (ii)
relating to waivers of rights or precluding any party from asserting claims or defenses or for
obtaining certain rights or remedies, (iii) requiring the resolution of any controversies, disputes
or claims by arbitration or by reference to a third-party expert, (iv) restricting access to courts
or to legal or equitable remedies or affecting the jurisdiction or venue of courts or purporting to
grant the remedy of specific performance or other equitable remedy, (v) relating to the
severability of invalid terms, the reformation of contracts and similar provisions, (vi) to the
extent a court would take into account the reasonableness of economic remedies including without
limitation, penalties or liquidated damages, (vii) purporting to require parties to negotiate or
agree in the future, (viii) whether a “best efforts” or similar clause sets an objective goal to be
accomplished, (ix) provisions purporting to permit cumulative remedies, or (x) the enforceability
of provisions to the effect that terms may not be waived or modified except in writing may be
limited under certain circumstances.
In the foregoing opinions, phrases such as “to our knowledge,” “known to us” and those with
equivalent wording refer to the conscious awareness of information by the lawyers of this firm who
have provided services for the Issuer since the beginning of this calendar year.
Our opinion is limited in all respects to matters governed by the Federal laws of the United
States, the laws of the State of Texas and the contract laws of the State of New York, in each case
as in effect on the date hereof. The opinions expressed herein are for your benefit and may be
relied upon only by you and may not be given or described to any other person without our prior
written consent. The opinions given are strictly limited to the matters stated herein and no
implied opinions are to be inferred from anything stated herein, and without limiting the
generality of the foregoing we express no opinion with respect to any bankruptcy or creditors
rights laws or any federal or state securities or antifraud law, rule or regulation except as
otherwise specifically stated herein. This opinion speaks as of the date hereof, and we disclaim
any obligation to update this opinion.
Exhibit C-1
Exhibit C-2
Form of Opinion of Issuer’s General Counsel
1. The authorized capital stock of the Issuer is as set forth in the Registration Statement
and the Prospectus under the caption “Description of Capital Stock” and, since the dates thereof,
there has been no change in the authorized capital stock of the Issuer. The issued and outstanding
capital stock of the Issuer has been validly issued, fully paid and nonassessable.
2. Each Subsidiary has been incorporated and is existing and in good standing under the laws
of the jurisdiction of its incorporation with all necessary corporate power and authority to own,
lease and operate its properties and conduct its business as described in the Registration
Statement, Disclosure Package and Prospectus Supplement.
3. The issuance and sale of the Securities by the Issuer (and the issuance of the Underlying
Shares upon conversion) is not subject to any preemptive or other similar rights of any security
holder of the Issuer under the Issuer’s Articles of Incorporation or Bylaws or, to my knowledge,
any agreement. To my knowledge, except as disclosed in the Registration Statement and the
Prospectus, there are no preemptive or other rights to subscribe for or to purchase or any
restriction upon the voting or transfer of any securities of the Issuer pursuant to the Issuer’s
Articles of Incorporation or Bylaws or any agreements known to me. To my knowledge, there are no
persons with registration rights or other similar rights to have any securities registered pursuant
to the Registration Statement, other than as described in the Registration Statement or as have
been waived or satisfied.
4. To my knowledge, other than as set forth in the Registration Statement, the Disclosure
Package or the Prospectus Supplement, there is no action, suit or proceeding, in each case pending
or threatened against the Issuer before any court, administrative agency or governmental authority
of the United States or the State of Texas which, if adversely determined, would have a material
adverse effect on the business and operations of Issuer or on its legal ability to perform its
obligations under the Agreement.
5. To my knowledge, all contracts and other documents required to be filed as exhibits to, or
described in, the Registration Statement have been so filed with the Commission or are fairly
described in the Registration Statement, as the case may be.
6. To my knowledge, no stop order suspending the effectiveness of the Registration Statement
has been issued and no proceedings for that purpose have been instituted or are threatened or
pending.
I have participated in conferences with officers and other representatives of the Issuer, your
representatives, your counsel and representatives of the independent registered public accounting
firm of the Issuer at which conferences the contents of the Registration Statement, the Prospectus
and the Disclosure Package and related matters were discussed and, although I did not independently
verify such information and am not
passing upon and do not assume any responsibility for the accuracy, completeness or fairness
of the statements contained in the Registration Statement, the Prospectus and the Disclosure
Package, I advise you that on the basis of the foregoing, no facts have come to my attention which
lead me to believe that
Exhibit C-2
(A) the Registration Statement (except for (i) the financial statements and
schedules contained therein or omitted therefrom (including the notes thereto and the auditor’s
report thereon), (ii) the summary reserve reports of each of the Issuer’s independent petroleum
engineers included therein, or (iii) the other accounting, financial or reserve engineering data
contained therein or omitted therefrom) at its latest Effective Date contained any untrue statement
of a material fact or omitted to state a material fact required to be stated therein or necessary
to make the statements therein not misleading, or (B) the Prospectus as amended or supplemented
(except for (i) the financial statements and schedules contained therein or omitted therefrom
(including the notes thereto and the auditor’s report thereon), (ii) the summary reserve reports of
each of the Issuer’s independent petroleum engineers included therein or (iii) the other
accounting, financial or reserve engineering data contained therein or omitted therefrom, as to
which I have not been asked to comment) on the date thereof contained any untrue statement of a
material fact or omitted to state a material fact necessary to make the statements therein, in the
light of the circumstances under which they were made, not misleading, or (C) the Disclosure
Package (except for (i) the financial statements and schedules contained therein or omitted
therefrom (including the notes thereto and the auditor’s report thereon), (ii) the summary reserve
reports of each of the Issuer’s independent petroleum engineers included therein or (iii) the other
accounting, financial or reserve engineering data contained therein or omitted therefrom, as to
which I have not been asked to comment) as of the Applicable Time contained any untrue statement of
a material fact or omitted to state a material fact necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading.
The opinions herein expressed are subject to the following qualifications:
A. The opinions expressed herein are limited to matters governed by the laws of the State of
Texas, the corporate laws of the State of Delaware and the federal laws of the United States of
America. I am only admitted to practice law in the State of Texas.
B. The opinions expressed herein are limited to the matters stated herein, and no opinion is
implied or may be inferred beyond the matters expressly stated herein and without limiting the
generality of the foregoing I express no opinion with respect to any bankruptcy or creditors rights
laws or any federal or state securities or antifraud law, rule or regulation except as otherwise
specifically stated herein. The opinions expressed herein are based upon and rely upon the current
status of the law in the applicable jurisdiction and in all respects are subject to and may be
limited by future legislation as well as by developing case law. The opinions expressed herein are
based solely upon applicable laws, statutes, ordinances, rules and regulations and facts, all as in
existence on this date, and I express no opinion as to the effect which any future amendments,
changes, additions or modifications thereof may have upon the opinions expressed herein, and I
assume no obligation to update or supplement such opinions to reflect any facts or circumstances
which may hereafter come to my attention or any changes in law which may hereafter occur.
C. The opinions expressed herein are legal opinions only and do not constitute a guarantee or
warranty of the matters discussed herein.
D. The opinions expressed herein are rendered solely for your benefit in connection with the
transactions described above. Except as expressly permitted by me in
Exhibit C-2
writing, these opinions may
not be used or relied upon by any other person and may not be disclosed, quoted, filed with a
governmental agency or otherwise referred to without my prior written consent in each instance.
E. In the foregoing opinions, phrases such as “to my knowledge,” “known to me” and those with
equivalent wording refer to my conscious awareness of information. In my capacity as General
Counsel, I have participated in numerous internal company meetings, made inquiries of such
individuals as I deemed appropriate and have examined records that I deemed relevant as a basis for
the opinions expressed above.
Exhibit C-2